<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>3 Upper Extremity and Thoracic Outlet | Vascular Surgery Exam Prep</title>
  <meta name="description" content="This is an ebook version of exam preparation content produced for Audible Bleeding: The Vascular Surgery Podcast, powered by the Society for Vascular Surgery" />
  <meta name="generator" content="bookdown 0.29 and GitBook 2.6.7" />

  <meta property="og:title" content="3 Upper Extremity and Thoracic Outlet | Vascular Surgery Exam Prep" />
  <meta property="og:type" content="book" />
  
  <meta property="og:description" content="This is an ebook version of exam preparation content produced for Audible Bleeding: The Vascular Surgery Podcast, powered by the Society for Vascular Surgery" />
  <meta name="github-repo" content="https://github.com/adam-mdmph/VS-Exam-Prep" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="3 Upper Extremity and Thoracic Outlet | Vascular Surgery Exam Prep" />
  
  <meta name="twitter:description" content="This is an ebook version of exam preparation content produced for Audible Bleeding: The Vascular Surgery Podcast, powered by the Society for Vascular Surgery" />
  

<meta name="author" content="Editors: Adam Johnson, MD, MPH; Matt Smith, MD, PhD; and Audible Bleeding" />



  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="152x152" href="images/apple_icon.png" />
  
<link rel="prev" href="cerebrovascular.html"/>
<link rel="next" href="abdominal-aneurysms.html"/>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.1.0/anchor-sections.css" rel="stylesheet" />
<link href="libs/anchor-sections-1.1.0/anchor-sections-hash.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.1.0/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">VS Exam Prep</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> About</a>
<ul>
<li class="chapter" data-level="1.1" data-path="index.html"><a href="index.html#usage"><i class="fa fa-check"></i><b>1.1</b> Usage</a></li>
<li class="chapter" data-level="1.2" data-path="index.html"><a href="index.html#comments-questions-or-contributions"><i class="fa fa-check"></i><b>1.2</b> Comments, Questions or Contributions</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="cerebrovascular.html"><a href="cerebrovascular.html"><i class="fa fa-check"></i><b>2</b> Cerebrovascular</a>
<ul>
<li class="chapter" data-level="2.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#available-guidelines"><i class="fa fa-check"></i><b>2.1</b> Available Guidelines</a></li>
<li class="chapter" data-level="2.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#presentation-and-diagnosis"><i class="fa fa-check"></i><b>2.2</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="2.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#management"><i class="fa fa-check"></i><b>2.3</b> Management</a>
<ul>
<li class="chapter" data-level="2.3.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#medical-management---asymptomatic-patients"><i class="fa fa-check"></i><b>2.3.1</b> Medical Management - Asymptomatic Patients</a></li>
<li class="chapter" data-level="2.3.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#medical-management---symptomatic-patients"><i class="fa fa-check"></i><b>2.3.2</b> Medical Management - Symptomatic Patients</a></li>
<li class="chapter" data-level="2.3.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#surgery---carotid-endarterectomy"><i class="fa fa-check"></i><b>2.3.3</b> Surgery - Carotid Endarterectomy</a></li>
<li class="chapter" data-level="2.3.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#endovascular---carotid-artery-stenting"><i class="fa fa-check"></i><b>2.3.4</b> Endovascular - Carotid Artery Stenting</a></li>
<li class="chapter" data-level="2.3.5" data-path="cerebrovascular.html"><a href="cerebrovascular.html#summary-of-prospective-trials"><i class="fa fa-check"></i><b>2.3.5</b> Summary of Prospective Trials</a></li>
</ul></li>
<li class="chapter" data-level="2.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#uncommon-carotid-disease"><i class="fa fa-check"></i><b>2.4</b> Uncommon Carotid Disease</a>
<ul>
<li class="chapter" data-level="2.4.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#complicated-extracranial-occlusive-disease"><i class="fa fa-check"></i><b>2.4.1</b> Complicated Extracranial Occlusive Disease</a></li>
<li class="chapter" data-level="2.4.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#vertebrobasilar-disease"><i class="fa fa-check"></i><b>2.4.2</b> Vertebrobasilar Disease</a></li>
<li class="chapter" data-level="2.4.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-artery-dissection"><i class="fa fa-check"></i><b>2.4.3</b> Carotid artery dissection</a></li>
<li class="chapter" data-level="2.4.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#internal-carotid-artery-aneurysms"><i class="fa fa-check"></i><b>2.4.4</b> Internal Carotid Artery Aneurysms</a></li>
<li class="chapter" data-level="2.4.5" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-body-tumors-cbt"><i class="fa fa-check"></i><b>2.4.5</b> Carotid Body Tumors (CBT)</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html"><i class="fa fa-check"></i><b>3</b> Upper Extremity and Thoracic Outlet</a>
<ul>
<li class="chapter" data-level="3.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#overview-of-upper-extremity-disease"><i class="fa fa-check"></i><b>3.1</b> Overview of Upper Extremity Disease</a>
<ul>
<li class="chapter" data-level="3.1.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#anatomy"><i class="fa fa-check"></i><b>3.1.1</b> Anatomy</a></li>
<li class="chapter" data-level="3.1.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#epidemiology-etiology-and-diagnostic-evaluation"><i class="fa fa-check"></i><b>3.1.2</b> Epidemiology, Etiology, and Diagnostic Evaluation</a></li>
<li class="chapter" data-level="3.1.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#evaluation"><i class="fa fa-check"></i><b>3.1.3</b> Evaluation</a></li>
</ul></li>
<li class="chapter" data-level="3.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vaso-occlusive-disease"><i class="fa fa-check"></i><b>3.2</b> Vaso-occlusive Disease</a>
<ul>
<li class="chapter" data-level="3.2.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#acute-limb-ischemia"><i class="fa fa-check"></i><b>3.2.1</b> Acute Limb Ischemia</a></li>
<li class="chapter" data-level="3.2.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#chronic-limb-threatening-ischemia"><i class="fa fa-check"></i><b>3.2.2</b> Chronic Limb Threatening Ischemia</a></li>
</ul></li>
<li class="chapter" data-level="3.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vasospastic-disorders"><i class="fa fa-check"></i><b>3.3</b> Vasospastic Disorders</a>
<ul>
<li class="chapter" data-level="3.3.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#iatrogenic-or-vasopressor-induced-ischemia"><i class="fa fa-check"></i><b>3.3.1</b> Iatrogenic or Vasopressor Induced Ischemia</a></li>
<li class="chapter" data-level="3.3.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#raynauds-phenomenon"><i class="fa fa-check"></i><b>3.3.2</b> Raynaud’s Phenomenon</a></li>
<li class="chapter" data-level="3.3.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#ergotism"><i class="fa fa-check"></i><b>3.3.3</b> Ergotism</a></li>
<li class="chapter" data-level="3.3.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#buergers-disease"><i class="fa fa-check"></i><b>3.3.4</b> Buerger’s Disease</a></li>
<li class="chapter" data-level="3.3.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#large-vasculitis"><i class="fa fa-check"></i><b>3.3.5</b> Large Artery Vasculitis</a></li>
<li class="chapter" data-level="3.3.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#other-vasculitis-syndromes"><i class="fa fa-check"></i><b>3.3.6</b> Other Vasculitis syndromes</a></li>
</ul></li>
<li class="chapter" data-level="3.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#aneurysmal-disease"><i class="fa fa-check"></i><b>3.4</b> Aneurysmal Disease</a>
<ul>
<li class="chapter" data-level="3.4.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#subclavian-artery-aneurysms"><i class="fa fa-check"></i><b>3.4.1</b> Subclavian Artery Aneurysms</a></li>
<li class="chapter" data-level="3.4.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#axillary-artery-aneurysms"><i class="fa fa-check"></i><b>3.4.2</b> Axillary Artery Aneurysms</a></li>
<li class="chapter" data-level="3.4.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#brachial-artery-aneurysms"><i class="fa fa-check"></i><b>3.4.3</b> Brachial Artery Aneurysms</a></li>
<li class="chapter" data-level="3.4.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#radial-artery-pseudoaneurysm"><i class="fa fa-check"></i><b>3.4.4</b> Radial Artery Pseudoaneurysm</a></li>
</ul></li>
<li class="chapter" data-level="3.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#occupational-vascular-disease"><i class="fa fa-check"></i><b>3.5</b> Occupational Vascular Disease</a>
<ul>
<li class="chapter" data-level="3.5.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#hand-arm-vibration-syndrome"><i class="fa fa-check"></i><b>3.5.1</b> Hand-Arm Vibration Syndrome</a></li>
<li class="chapter" data-level="3.5.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#hypothenar-hammer-syndrome"><i class="fa fa-check"></i><b>3.5.2</b> Hypothenar hammer syndrome</a></li>
<li class="chapter" data-level="3.5.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#environmental-exposures"><i class="fa fa-check"></i><b>3.5.3</b> Environmental Exposures</a></li>
<li class="chapter" data-level="3.5.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#sports-medicine"><i class="fa fa-check"></i><b>3.5.4</b> Sports Medicine</a></li>
</ul></li>
<li class="chapter" data-level="3.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vascular-trauma-upper-extremity"><i class="fa fa-check"></i><b>3.6</b> Vascular Trauma-Upper Extremity</a>
<ul>
<li class="chapter" data-level="3.6.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#subclavian-artery-trauma"><i class="fa fa-check"></i><b>3.6.1</b> Subclavian Artery Trauma</a></li>
<li class="chapter" data-level="3.6.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#axillary-artery-trauma"><i class="fa fa-check"></i><b>3.6.2</b> Axillary Artery Trauma</a></li>
<li class="chapter" data-level="3.6.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#brachial-artery-trauma"><i class="fa fa-check"></i><b>3.6.3</b> Brachial Artery Trauma</a></li>
<li class="chapter" data-level="3.6.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#radialulnar-artery-trauma"><i class="fa fa-check"></i><b>3.6.4</b> Radial/ulnar artery trauma</a></li>
</ul></li>
<li class="chapter" data-level="3.7" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#compression-syndromes"><i class="fa fa-check"></i><b>3.7</b> Compression Syndromes</a>
<ul>
<li class="chapter" data-level="3.7.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#quadrilateral-space-syndrome"><i class="fa fa-check"></i><b>3.7.1</b> Quadrilateral space syndrome</a></li>
<li class="chapter" data-level="3.7.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#humeral-head-compression-of-axillary-artery"><i class="fa fa-check"></i><b>3.7.2</b> Humeral head compression of axillary artery</a></li>
</ul></li>
<li class="chapter" data-level="3.8" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#thoracic-outlet-syndrome"><i class="fa fa-check"></i><b>3.8</b> Thoracic Outlet Syndrome</a>
<ul>
<li class="chapter" data-level="3.8.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#anatomy-1"><i class="fa fa-check"></i><b>3.8.1</b> Anatomy</a></li>
<li class="chapter" data-level="3.8.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#presentation-5"><i class="fa fa-check"></i><b>3.8.2</b> Presentation</a></li>
<li class="chapter" data-level="3.8.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#evaluation-9"><i class="fa fa-check"></i><b>3.8.3</b> Evaluation</a></li>
<li class="chapter" data-level="3.8.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#management-10"><i class="fa fa-check"></i><b>3.8.4</b> Management</a></li>
<li class="chapter" data-level="3.8.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vtos"><i class="fa fa-check"></i><b>3.8.5</b> vTOS</a></li>
<li class="chapter" data-level="3.8.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#atos"><i class="fa fa-check"></i><b>3.8.6</b> aTOS</a></li>
<li class="chapter" data-level="3.8.7" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#ntos"><i class="fa fa-check"></i><b>3.8.7</b> nTOS</a></li>
</ul></li>
<li class="chapter" data-level="3.9" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#upper-extremity-lymphedema"><i class="fa fa-check"></i><b>3.9</b> Upper Extremity Lymphedema</a>
<ul>
<li class="chapter" data-level="3.9.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#etiology-8"><i class="fa fa-check"></i><b>3.9.1</b> Etiology</a></li>
<li class="chapter" data-level="3.9.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#management-14"><i class="fa fa-check"></i><b>3.9.2</b> Management</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="4" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html"><i class="fa fa-check"></i><b>4</b> Abdominal Aneurysms</a>
<ul>
<li class="chapter" data-level="4.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#pathogenesis-presentation-and-risk-factors"><i class="fa fa-check"></i><b>4.1</b> Pathogenesis, presentation and risk factors</a></li>
<li class="chapter" data-level="4.2" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#evaluation-and-diagnosis"><i class="fa fa-check"></i><b>4.2</b> Evaluation and Diagnosis</a>
<ul>
<li class="chapter" data-level="4.2.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#imaging"><i class="fa fa-check"></i><b>4.2.1</b> Imaging</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#management-15"><i class="fa fa-check"></i><b>4.3</b> Management</a>
<ul>
<li class="chapter" data-level="4.3.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#evar"><i class="fa fa-check"></i><b>4.3.1</b> EVAR</a></li>
<li class="chapter" data-level="4.3.2" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#open-repair"><i class="fa fa-check"></i><b>4.3.2</b> Open Repair</a></li>
<li class="chapter" data-level="4.3.3" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#ruptured-aneurysms"><i class="fa fa-check"></i><b>4.3.3</b> Ruptured Aneurysms</a></li>
</ul></li>
<li class="chapter" data-level="4.4" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#iliacperipheral-aneurysms"><i class="fa fa-check"></i><b>4.4</b> Iliac/Peripheral Aneurysms</a>
<ul>
<li class="chapter" data-level="4.4.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#demographics-2"><i class="fa fa-check"></i><b>4.4.1</b> Demographics</a></li>
<li class="chapter" data-level="4.4.2" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#presentation-9"><i class="fa fa-check"></i><b>4.4.2</b> Presentation</a></li>
<li class="chapter" data-level="4.4.3" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#management-16"><i class="fa fa-check"></i><b>4.4.3</b> Management</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="5" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html"><i class="fa fa-check"></i><b>5</b> Lower Extremity Occlusive Disease</a>
<ul>
<li class="chapter" data-level="5.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#pathophysiology"><i class="fa fa-check"></i><b>5.1</b> Pathophysiology</a></li>
<li class="chapter" data-level="5.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#intermittent-claudication"><i class="fa fa-check"></i><b>5.2</b> Intermittent Claudication</a>
<ul>
<li class="chapter" data-level="5.2.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#history-clinical-examination"><i class="fa fa-check"></i><b>5.2.1</b> History / Clinical Examination</a></li>
<li class="chapter" data-level="5.2.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-17"><i class="fa fa-check"></i><b>5.2.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#chronic-limb-threatening-ischemia-1"><i class="fa fa-check"></i><b>5.3</b> Chronic Limb Threatening Ischemia</a>
<ul>
<li class="chapter" data-level="5.3.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#etiology-and-presentation"><i class="fa fa-check"></i><b>5.3.1</b> Etiology and Presentation</a></li>
<li class="chapter" data-level="5.3.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#evaluation-12"><i class="fa fa-check"></i><b>5.3.2</b> Evaluation</a></li>
<li class="chapter" data-level="5.3.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-18"><i class="fa fa-check"></i><b>5.3.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.4" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#acute-limb-ischemia-1"><i class="fa fa-check"></i><b>5.4</b> Acute Limb Ischemia</a>
<ul>
<li class="chapter" data-level="5.4.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#presentation-and-diagnosis-1"><i class="fa fa-check"></i><b>5.4.1</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="5.4.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-19"><i class="fa fa-check"></i><b>5.4.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.5" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#compartment-syndrome"><i class="fa fa-check"></i><b>5.5</b> Compartment Syndrome</a></li>
<li class="chapter" data-level="5.6" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#blue-toe-syndrome"><i class="fa fa-check"></i><b>5.6</b> Blue Toe Syndrome</a>
<ul>
<li class="chapter" data-level="5.6.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#etiology-and-presentation-1"><i class="fa fa-check"></i><b>5.6.1</b> Etiology and Presentation</a></li>
<li class="chapter" data-level="5.6.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#evaluation-13"><i class="fa fa-check"></i><b>5.6.2</b> Evaluation</a></li>
<li class="chapter" data-level="5.6.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-20"><i class="fa fa-check"></i><b>5.6.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.7" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#non-atheromatous-popliteal-artery-disease"><i class="fa fa-check"></i><b>5.7</b> Non-atheromatous Popliteal Artery Disease</a>
<ul>
<li class="chapter" data-level="5.7.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#popliteal-artery-entrapment-syndrome-paes"><i class="fa fa-check"></i><b>5.7.1</b> Popliteal Artery Entrapment Syndrome (PAES)</a></li>
<li class="chapter" data-level="5.7.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#cystic-adventitial-disease"><i class="fa fa-check"></i><b>5.7.2</b> Cystic Adventitial Disease</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html"><i class="fa fa-check"></i><b>6</b> Mesenteric Disease</a>
<ul>
<li class="chapter" data-level="6.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#acute-mesenteric-ischemia"><i class="fa fa-check"></i><b>6.1</b> Acute Mesenteric Ischemia</a>
<ul>
<li class="chapter" data-level="6.1.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#presentation-and-evaluation"><i class="fa fa-check"></i><b>6.1.1</b> Presentation and Evaluation</a></li>
<li class="chapter" data-level="6.1.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#management-23"><i class="fa fa-check"></i><b>6.1.2</b> Management</a></li>
<li class="chapter" data-level="6.1.3" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#other-etiologies"><i class="fa fa-check"></i><b>6.1.3</b> Other Etiologies</a></li>
</ul></li>
<li class="chapter" data-level="6.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#chronic-mesenteric-ischemia"><i class="fa fa-check"></i><b>6.2</b> Chronic Mesenteric Ischemia</a>
<ul>
<li class="chapter" data-level="6.2.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#presentation-and-evaluation-1"><i class="fa fa-check"></i><b>6.2.1</b> Presentation and Evaluation</a></li>
<li class="chapter" data-level="6.2.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#management-24"><i class="fa fa-check"></i><b>6.2.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="6.3" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#mesenteric-aneurysms"><i class="fa fa-check"></i><b>6.3</b> Mesenteric Aneurysms</a>
<ul>
<li class="chapter" data-level="6.3.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#sma-aneurysm"><i class="fa fa-check"></i><b>6.3.1</b> SMA Aneurysm</a></li>
<li class="chapter" data-level="6.3.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#splenic-aneurysm"><i class="fa fa-check"></i><b>6.3.2</b> Splenic Aneurysm</a></li>
</ul></li>
<li class="chapter" data-level="6.4" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#median-arcuate-ligament-syndrome-mals"><i class="fa fa-check"></i><b>6.4</b> Median Arcuate Ligament Syndrome (MALS)</a></li>
<li class="chapter" data-level="6.5" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#sma-syndrome"><i class="fa fa-check"></i><b>6.5</b> SMA Syndrome</a></li>
<li class="chapter" data-level="6.6" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#uterine-fibroids"><i class="fa fa-check"></i><b>6.6</b> Uterine Fibroids</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="renal.html"><a href="renal.html"><i class="fa fa-check"></i><b>7</b> Renal</a>
<ul>
<li class="chapter" data-level="7.1" data-path="renal.html"><a href="renal.html#pathophysiology-1"><i class="fa fa-check"></i><b>7.1</b> Pathophysiology</a></li>
<li class="chapter" data-level="7.2" data-path="renal.html"><a href="renal.html#medical-management-and-evaluation"><i class="fa fa-check"></i><b>7.2</b> Medical Management and Evaluation</a></li>
<li class="chapter" data-level="7.3" data-path="renal.html"><a href="renal.html#operative-managment"><i class="fa fa-check"></i><b>7.3</b> Operative Managment</a>
<ul>
<li class="chapter" data-level="7.3.1" data-path="renal.html"><a href="renal.html#endovascular-therapy"><i class="fa fa-check"></i><b>7.3.1</b> Endovascular Therapy</a></li>
<li class="chapter" data-level="7.3.2" data-path="renal.html"><a href="renal.html#open-surgery"><i class="fa fa-check"></i><b>7.3.2</b> Open Surgery</a></li>
</ul></li>
<li class="chapter" data-level="7.4" data-path="renal.html"><a href="renal.html#fibromuscular-dysplasia-fmd"><i class="fa fa-check"></i><b>7.4</b> Fibromuscular Dysplasia (FMD)</a></li>
<li class="chapter" data-level="7.5" data-path="renal.html"><a href="renal.html#renal-artery-aneurysms"><i class="fa fa-check"></i><b>7.5</b> Renal Artery Aneurysms</a>
<ul>
<li class="chapter" data-level="7.5.1" data-path="renal.html"><a href="renal.html#demographics-3"><i class="fa fa-check"></i><b>7.5.1</b> Demographics</a></li>
<li class="chapter" data-level="7.5.2" data-path="renal.html"><a href="renal.html#anatomy-2"><i class="fa fa-check"></i><b>7.5.2</b> Anatomy</a></li>
<li class="chapter" data-level="7.5.3" data-path="renal.html"><a href="renal.html#presentation-10"><i class="fa fa-check"></i><b>7.5.3</b> Presentation</a></li>
<li class="chapter" data-level="7.5.4" data-path="renal.html"><a href="renal.html#management-25"><i class="fa fa-check"></i><b>7.5.4</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="7.6" data-path="renal.html"><a href="renal.html#renal-artery-dissection"><i class="fa fa-check"></i><b>7.6</b> Renal Artery Dissection</a></li>
<li class="chapter" data-level="7.7" data-path="renal.html"><a href="renal.html#renal-vein-thrombosis"><i class="fa fa-check"></i><b>7.7</b> Renal Vein Thrombosis</a>
<ul>
<li class="chapter" data-level="7.7.1" data-path="renal.html"><a href="renal.html#diagnosis"><i class="fa fa-check"></i><b>7.7.1</b> Diagnosis</a></li>
<li class="chapter" data-level="7.7.2" data-path="renal.html"><a href="renal.html#management-26"><i class="fa fa-check"></i><b>7.7.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="7.8" data-path="renal.html"><a href="renal.html#renal-arteriovenous-fistula"><i class="fa fa-check"></i><b>7.8</b> Renal Arteriovenous Fistula</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html"><i class="fa fa-check"></i><b>8</b> Thoracic Aorta</a>
<ul>
<li class="chapter" data-level="8.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aortic-dissection"><i class="fa fa-check"></i><b>8.1</b> Aortic Dissection</a>
<ul>
<li class="chapter" data-level="8.1.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#demographics-4"><i class="fa fa-check"></i><b>8.1.1</b> Demographics</a></li>
<li class="chapter" data-level="8.1.2" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#evaluation-16"><i class="fa fa-check"></i><b>8.1.2</b> Evaluation</a></li>
<li class="chapter" data-level="8.1.3" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#management-27"><i class="fa fa-check"></i><b>8.1.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="8.2" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aneurysms---thoracic-and-thoracoabdominal"><i class="fa fa-check"></i><b>8.2</b> Aneurysms - Thoracic and Thoracoabdominal</a>
<ul>
<li class="chapter" data-level="8.2.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#anatomy-and-demographics"><i class="fa fa-check"></i><b>8.2.1</b> Anatomy and Demographics</a></li>
<li class="chapter" data-level="8.2.2" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#management-28"><i class="fa fa-check"></i><b>8.2.2</b> Management</a></li>
<li class="chapter" data-level="8.2.3" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#additional-resources"><i class="fa fa-check"></i><b>8.2.3</b> Additional Resources</a></li>
</ul></li>
<li class="chapter" data-level="8.3" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aortopathies"><i class="fa fa-check"></i><b>8.3</b> Aortopathies</a>
<ul>
<li class="chapter" data-level="8.3.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#links"><i class="fa fa-check"></i><b>8.3.1</b> LINKS:</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="9" data-path="venous-disease.html"><a href="venous-disease.html"><i class="fa fa-check"></i><b>9</b> Venous Disease</a>
<ul>
<li class="chapter" data-level="9.1" data-path="venous-disease.html"><a href="venous-disease.html#chronic-venous-insufficiency"><i class="fa fa-check"></i><b>9.1</b> Chronic Venous Insufficiency</a>
<ul>
<li class="chapter" data-level="9.1.1" data-path="venous-disease.html"><a href="venous-disease.html#terminology-and-presentation"><i class="fa fa-check"></i><b>9.1.1</b> Terminology and Presentation</a></li>
<li class="chapter" data-level="9.1.2" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-17"><i class="fa fa-check"></i><b>9.1.2</b> Evaluation</a></li>
<li class="chapter" data-level="9.1.3" data-path="venous-disease.html"><a href="venous-disease.html#management-29"><i class="fa fa-check"></i><b>9.1.3</b> Management</a></li>
<li class="chapter" data-level="9.1.4" data-path="venous-disease.html"><a href="venous-disease.html#other-complications-of-superficial-venous-disease"><i class="fa fa-check"></i><b>9.1.4</b> Other Complications of Superficial Venous Disease</a></li>
</ul></li>
<li class="chapter" data-level="9.2" data-path="venous-disease.html"><a href="venous-disease.html#acute-thrombosis---deep-venous-thrombosis-dvt"><i class="fa fa-check"></i><b>9.2</b> Acute Thrombosis - Deep venous thrombosis (DVT)</a>
<ul>
<li class="chapter" data-level="9.2.1" data-path="venous-disease.html"><a href="venous-disease.html#physiology"><i class="fa fa-check"></i><b>9.2.1</b> Physiology</a></li>
<li class="chapter" data-level="9.2.2" data-path="venous-disease.html"><a href="venous-disease.html#etiology-10"><i class="fa fa-check"></i><b>9.2.2</b> Etiology</a></li>
<li class="chapter" data-level="9.2.3" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-18"><i class="fa fa-check"></i><b>9.2.3</b> Evaluation</a></li>
<li class="chapter" data-level="9.2.4" data-path="venous-disease.html"><a href="venous-disease.html#management-30"><i class="fa fa-check"></i><b>9.2.4</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="9.3" data-path="venous-disease.html"><a href="venous-disease.html#phlegmasia"><i class="fa fa-check"></i><b>9.3</b> Phlegmasia</a></li>
<li class="chapter" data-level="9.4" data-path="venous-disease.html"><a href="venous-disease.html#deep-venous-obstruction"><i class="fa fa-check"></i><b>9.4</b> Deep Venous Obstruction</a>
<ul>
<li class="chapter" data-level="9.4.1" data-path="venous-disease.html"><a href="venous-disease.html#etiology-11"><i class="fa fa-check"></i><b>9.4.1</b> Etiology</a></li>
<li class="chapter" data-level="9.4.2" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-19"><i class="fa fa-check"></i><b>9.4.2</b> Evaluation</a></li>
<li class="chapter" data-level="9.4.3" data-path="venous-disease.html"><a href="venous-disease.html#management-31"><i class="fa fa-check"></i><b>9.4.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="9.5" data-path="venous-disease.html"><a href="venous-disease.html#pelvic-congestive-syndrome"><i class="fa fa-check"></i><b>9.5</b> Pelvic Congestive Syndrome</a>
<ul>
<li class="chapter" data-level="9.5.1" data-path="venous-disease.html"><a href="venous-disease.html#presentation-12"><i class="fa fa-check"></i><b>9.5.1</b> Presentation</a></li>
<li class="chapter" data-level="9.5.2" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-and-management"><i class="fa fa-check"></i><b>9.5.2</b> Evaluation and Management</a></li>
</ul></li>
<li class="chapter" data-level="9.6" data-path="venous-disease.html"><a href="venous-disease.html#venous-trauma"><i class="fa fa-check"></i><b>9.6</b> Venous Trauma</a></li>
</ul></li>
<li class="chapter" data-level="10" data-path="vascular-trauma.html"><a href="vascular-trauma.html"><i class="fa fa-check"></i><b>10</b> Vascular Trauma</a>
<ul>
<li class="chapter" data-level="10.1" data-path="vascular-trauma.html"><a href="vascular-trauma.html#peripheral"><i class="fa fa-check"></i><b>10.1</b> Peripheral</a></li>
<li class="chapter" data-level="10.2" data-path="vascular-trauma.html"><a href="vascular-trauma.html#abdominal-arterial"><i class="fa fa-check"></i><b>10.2</b> Abdominal Arterial</a></li>
<li class="chapter" data-level="10.3" data-path="vascular-trauma.html"><a href="vascular-trauma.html#abdominal-venous"><i class="fa fa-check"></i><b>10.3</b> Abdominal Venous</a></li>
<li class="chapter" data-level="10.4" data-path="vascular-trauma.html"><a href="vascular-trauma.html#cerebrovascular-trauma"><i class="fa fa-check"></i><b>10.4</b> Cerebrovascular Trauma</a></li>
<li class="chapter" data-level="10.5" data-path="vascular-trauma.html"><a href="vascular-trauma.html#endovascular-approaches"><i class="fa fa-check"></i><b>10.5</b> Endovascular Approaches</a></li>
</ul></li>
<li class="chapter" data-level="11" data-path="angioaccess.html"><a href="angioaccess.html"><i class="fa fa-check"></i><b>11</b> Angioaccess</a>
<ul>
<li class="chapter" data-level="11.1" data-path="angioaccess.html"><a href="angioaccess.html#planning-access-creation"><i class="fa fa-check"></i><b>11.1</b> Planning access creation</a></li>
<li class="chapter" data-level="11.2" data-path="angioaccess.html"><a href="angioaccess.html#techniques-for-access-creation"><i class="fa fa-check"></i><b>11.2</b> Techniques for access creation</a></li>
<li class="chapter" data-level="11.3" data-path="angioaccess.html"><a href="angioaccess.html#maintenance-and-complications"><i class="fa fa-check"></i><b>11.3</b> Maintenance and complications</a>
<ul>
<li class="chapter" data-level="11.3.1" data-path="angioaccess.html"><a href="angioaccess.html#failure-to-mature"><i class="fa fa-check"></i><b>11.3.1</b> Failure to mature</a></li>
<li class="chapter" data-level="11.3.2" data-path="angioaccess.html"><a href="angioaccess.html#access-failure"><i class="fa fa-check"></i><b>11.3.2</b> Access Failure</a></li>
<li class="chapter" data-level="11.3.3" data-path="angioaccess.html"><a href="angioaccess.html#sec-steal-syndrome"><i class="fa fa-check"></i><b>11.3.3</b> Steal Syndrome</a></li>
<li class="chapter" data-level="11.3.4" data-path="angioaccess.html"><a href="angioaccess.html#neuropathy-and-neuropraxia"><i class="fa fa-check"></i><b>11.3.4</b> Neuropathy and Neuropraxia</a></li>
<li class="chapter" data-level="11.3.5" data-path="angioaccess.html"><a href="angioaccess.html#perioperative-neuropraxia"><i class="fa fa-check"></i><b>11.3.5</b> Perioperative neuropraxia</a></li>
<li class="chapter" data-level="11.3.6" data-path="angioaccess.html"><a href="angioaccess.html#bleeding-and-aneurysm"><i class="fa fa-check"></i><b>11.3.6</b> Bleeding and Aneurysm</a></li>
</ul></li>
<li class="chapter" data-level="11.4" data-path="angioaccess.html"><a href="angioaccess.html#dialysis-catheters"><i class="fa fa-check"></i><b>11.4</b> Dialysis Catheters</a></li>
<li class="chapter" data-level="11.5" data-path="angioaccess.html"><a href="angioaccess.html#peritoneal-dialysis"><i class="fa fa-check"></i><b>11.5</b> Peritoneal Dialysis</a></li>
</ul></li>
<li class="chapter" data-level="12" data-path="vascular-lab.html"><a href="vascular-lab.html"><i class="fa fa-check"></i><b>12</b> Vascular Lab</a>
<ul>
<li class="chapter" data-level="12.1" data-path="vascular-lab.html"><a href="vascular-lab.html#overview"><i class="fa fa-check"></i><b>12.1</b> <strong>Overview</strong></a>
<ul>
<li class="chapter" data-level="12.1.1" data-path="vascular-lab.html"><a href="vascular-lab.html#waveforms"><i class="fa fa-check"></i><b>12.1.1</b> Waveforms</a></li>
</ul></li>
<li class="chapter" data-level="12.2" data-path="vascular-lab.html"><a href="vascular-lab.html#extracranial"><i class="fa fa-check"></i><b>12.2</b> Extracranial</a></li>
<li class="chapter" data-level="12.3" data-path="vascular-lab.html"><a href="vascular-lab.html#intracranial"><i class="fa fa-check"></i><b>12.3</b> Intracranial</a></li>
<li class="chapter" data-level="12.4" data-path="vascular-lab.html"><a href="vascular-lab.html#upper-extremity"><i class="fa fa-check"></i><b>12.4</b> Upper Extremity</a>
<ul>
<li class="chapter" data-level="12.4.1" data-path="vascular-lab.html"><a href="vascular-lab.html#hemodialysis-access"><i class="fa fa-check"></i><b>12.4.1</b> Hemodialysis Access</a></li>
</ul></li>
<li class="chapter" data-level="12.5" data-path="vascular-lab.html"><a href="vascular-lab.html#lower-extremity"><i class="fa fa-check"></i><b>12.5</b> Lower Extremity</a>
<ul>
<li class="chapter" data-level="12.5.1" data-path="vascular-lab.html"><a href="vascular-lab.html#pathologies"><i class="fa fa-check"></i><b>12.5.1</b> Pathologies</a></li>
</ul></li>
<li class="chapter" data-level="12.6" data-path="vascular-lab.html"><a href="vascular-lab.html#abdominal"><i class="fa fa-check"></i><b>12.6</b> Abdominal</a>
<ul>
<li class="chapter" data-level="12.6.1" data-path="vascular-lab.html"><a href="vascular-lab.html#aorta"><i class="fa fa-check"></i><b>12.6.1</b> Aorta</a></li>
<li class="chapter" data-level="12.6.2" data-path="vascular-lab.html"><a href="vascular-lab.html#mesenteric-vasculature"><i class="fa fa-check"></i><b>12.6.2</b> Mesenteric Vasculature</a></li>
<li class="chapter" data-level="12.6.3" data-path="vascular-lab.html"><a href="vascular-lab.html#portal-vein"><i class="fa fa-check"></i><b>12.6.3</b> Portal Vein</a></li>
<li class="chapter" data-level="12.6.4" data-path="vascular-lab.html"><a href="vascular-lab.html#renal-arteries"><i class="fa fa-check"></i><b>12.6.4</b> Renal arteries</a></li>
</ul></li>
<li class="chapter" data-level="12.7" data-path="vascular-lab.html"><a href="vascular-lab.html#venous"><i class="fa fa-check"></i><b>12.7</b> Venous</a></li>
<li class="chapter" data-level="12.8" data-path="vascular-lab.html"><a href="vascular-lab.html#artifacts"><i class="fa fa-check"></i><b>12.8</b> Artifacts</a></li>
<li class="chapter" data-level="12.9" data-path="vascular-lab.html"><a href="vascular-lab.html#accreditation-and-credentialling"><i class="fa fa-check"></i><b>12.9</b> Accreditation and Credentialling</a></li>
</ul></li>
<li class="chapter" data-level="13" data-path="endovascular-2.html"><a href="endovascular-2.html"><i class="fa fa-check"></i><b>13</b> Endovascular</a>
<ul>
<li class="chapter" data-level="13.1" data-path="endovascular-2.html"><a href="endovascular-2.html#vascular-access"><i class="fa fa-check"></i><b>13.1</b> Vascular Access</a></li>
<li class="chapter" data-level="13.2" data-path="endovascular-2.html"><a href="endovascular-2.html#access-comp"><i class="fa fa-check"></i><b>13.2</b> Complications</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Vascular Surgery Exam Prep</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="upper-extremity-and-thoracic-outlet" class="section level1 hasAnchor" number="3">
<h1><span class="header-section-number">3</span> Upper Extremity and Thoracic Outlet<a href="upper-extremity-and-thoracic-outlet.html#upper-extremity-and-thoracic-outlet" class="anchor-section" aria-label="Anchor link to header"></a></h1>
<p><strong>UNDER CONSTRUCTION - This Chapter is Currently in DRAFT mode</strong></p>
<p><strong>21 Jan 2021</strong>: <em>Kush Sharma, MD and Ashraf Mansour, MD</em></p>
<div id="overview-of-upper-extremity-disease" class="section level2 hasAnchor" number="3.1">
<h2><span class="header-section-number">3.1</span> Overview of Upper Extremity Disease<a href="upper-extremity-and-thoracic-outlet.html#overview-of-upper-extremity-disease" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<audio controls> <source src='https://traffic.libsyn.com/audiblebleeding/VSITE_Upper_Extremity_post_auphonic.mp3' type='audio/mpeg'> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio>
<div id="anatomy" class="section level3 hasAnchor" number="3.1.1">
<h3><span class="header-section-number">3.1.1</span> Anatomy<a href="upper-extremity-and-thoracic-outlet.html#anatomy" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What are the zones of the upper
extremity?</strong><span class="citation"><sup>[<a href="#ref-illig57UpperExtremity2019" role="doc-biblioref">86</a>]</sup></span></p>
<p>Division of the upper extremity into three zones:</p>
<ol style="list-style-type: decimal">
<li><p>Intrathoracic Zone: Inclusive of the aortic arch and its branches,
innominate artery (dividing into right subclavian and right common
carotid), left subclavian artery and left common carotid artery, as
well as the innominate veins, and SVC.</p>
<ul>
<li>Arch classification helps determine difficulty of accessing the
right innominate from a femoral approach. Type 1 innominate does
not break the plane of the outer curve, Type 2 it is between the
outer curve and inner curve and Type 3 it falls below the inner
curve of the aortic arch.</li>
</ul></li>
<li><p>Thoracic Outlet: Extends from the base of neck to the axilla.
Includes the subclavian, proximal vertebral, and proximal axillary
arteries, as well as the corresponding veins).</p></li>
<li><p>Axilla to Fingers: The arm.</p></li>
</ol>
<p><strong>What are some common exposures for major upper extremity
arteries?</strong><span class="citation"><sup>[<a href="#ref-illig57UpperExtremity2019" role="doc-biblioref">86</a>,<a href="#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">87</a>]</sup></span></p>
<ol style="list-style-type: decimal">
<li><p><strong>Proximal Right Subclavian Artery:</strong> Access through a median
sternotomy.</p></li>
<li><p><strong>Proximal Left Subclavian Artery:</strong> An anterolateral thoracotomy is
required in emergent settings for proximal left subclavian artery
control. For proximal, mid and distal exposure is required a “trap
door” exposure is used: anterolateral thoracotomy, third space
sternotomy, and left supraclavicular incision.</p></li>
<li><p><strong>Mid and Distal Subclavian Artery</strong>: Access through a
supraclavicular Incision. After division of the platysma and
clavicular head of the SCM, a fat pat of varying thickness is
encountered which contains the omohyoid muscle. This should be
divided and placed supero-laterally. At this point, the anterior
scalene muscle is exposed medially with the phrenic nerve running in
a lateral to medial direction, which should be identified and
preserved. In a carotid/subclavian bypass division of the anterior
scalene should be performed as close to the first rib as possible.
Once divided the subclavian artery is exposed.</p></li>
<li><p><strong>Axillary Artery:</strong> Exposure is gained through an infraclavicular
incision, below the middle third of the clavicle. Pectoralis major
is divided and pectoralis minor is freed at the lateral margin of
the wound. The axillary vein should be identified and followed
supero-deeply to identify and expose the artery. Anatomically bound
by the first rib proximally and the lateral edge of the teres major
muscle distally. For exposure of the first part of the axillary
artery, the ipsilateral arm is abducted approximately 90 degrees and
a horizontal skin incision 2 cm below the middle third of the
clavicle should be made. The underlying pectoralis major is split by
bluntly separating the fibers, exposing the tough clavipectoral
fascia. At the lateral wound margin, the pectoralis minor can be
freed and laterally retracted. The axillary vein is the first
structure to be encountered in the fascia and the artery lies just
superior and deep to the vein. Make sure to protect the nerves of
the brachial plexus which lie deep to the first part of axillary
artery and are at risk of injury during blind placement of occluding
arterial clamps.</p></li>
<li><p><strong>Brachial Artery, Upper Arm:</strong> The brachial artery’s superficial
location makes it vulnerable to injury and accounts for most
vascular injuries of the upper extremities. Brachial artery exposure
involves a 5-8 cm longitudinal incision in the groove between the
biceps/triceps muscles on the medial aspect of the arm. In the lower
half of the arm, take care to avoid basilic vein damage as it runs
in the subcutaneous tissue. The neurovascular bundle is exposed by
incising the deep fascia at the medial border of the biceps muscle,
which then should be retracted anteriorly. The basilic vein should
be identified and retracted into the posterior wound. On opening the
brachial sheath the median nerve is the most superficial structure
and should be identified, protected and retracted. The brachial
artery lies deep to the median nerve and is flanked by two brachial
veins. Be mindful that the ulnar nerve lies posteriorly.</p></li>
<li><p><strong>Brachial Artery, Antecubital Fossa:</strong> Exposure of the brachial
artery in the antecubital fossa requires a transverse skin incision
1 cm distal to the midpoint of the antecubital crease. After
deepening, mobilize the basilic vein medially to avoid injury. The
medial antebrachial cutaneous nerve should be identified and
protected. The bicipital aponeurosis should be divided to exposure
the brachial artery, which is flanked by two deep veins crossing
tributaries. To isolate the brachial artery ligation and division of
these tributaries is required. The brachial artery bifurcates at the
radial tuberosity into its radial and ulnar branches. Immediately
after the ulnar artery arises from the bifurcation origin, it gives
off a short common interosseous branch, which bifurcates at the
hiatus in the proximal interosseous membrane.</p></li>
<li><p><strong>Radial Artery at the Wrist:</strong> This requires a 2-3 cm longitudinal
incision generally between the palpable radial artery and cephalic
vein. Incision of the antebrachial fascia medially to the radius
should expose the radial artery. Two veins accompany the artery and
should be dissected away to isolate the artery. The superficial
radial nerve and its medial/lateral branches course between the
cephalic vein and radial artery in this area.</p></li>
<li><p><strong>Ulnar Artery:</strong> The ulnar artery courses beneath the superficial
flexor muscles of the proximal forearm, emerging near the ulnar
border at the midpoint between the elbow and the wrist. In the
distal forearm, the ulnar artery runs just deep to the antebrachial
fascia and is easily exposed through a longitudinal incision placed
radially to the flexor carpi ulnaris. The palmar branch of the ulnar
nerve courses superficially to the antebrachial fascia and should be
preserved during arterial exposure to avoid injury.</p></li>
</ol>
<p><strong>What common aberrant upper extremity/arch anatomy is important to be
aware of?</strong></p>
<p>Thoracic aortic disease is associated with aberrant anatomy, with high
rates of bovine arch (25%), isolated L vertebral (6-8%), and aberrant R
subclavian (1-2%).<span class="citation"><sup>[<a href="#ref-dumfarth2015" role="doc-biblioref">88</a>]</sup></span></p>
<ol style="list-style-type: decimal">
<li><p><strong>Bovine Arch:</strong> Where the innominate and left common carotid
arteries share a common origin.<span class="citation"><sup>[<a href="#ref-layton2006" role="doc-biblioref">89</a>]</sup></span></p></li>
<li><p><strong>Aberrant Vertebral Artery:</strong> Where the vertebral artery arises
directly from the aortic arch.</p></li>
<li><p><strong>Aberrant Right Subclavian Artery:</strong> Where there is no innominate
artery and instead the right common carotid arises directly from the
aorta. Confusingly the right subclavian artery, then originates from
the aortic arch distal to the left subclavian artery. To supply the
right arm it therefore, needs to pass behind the esophagus.
(Dysphagia Lusoria)</p></li>
</ol>
</div>
<div id="epidemiology-etiology-and-diagnostic-evaluation" class="section level3 hasAnchor" number="3.1.2">
<h3><span class="header-section-number">3.1.2</span> Epidemiology, Etiology, and Diagnostic Evaluation<a href="upper-extremity-and-thoracic-outlet.html#epidemiology-etiology-and-diagnostic-evaluation" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>How does evaluation of upper extremity ischemia differentiate from
lower extremity ischemia?</strong></p>
<ul>
<li><p>Upper extremity ischemia &lt;5% of patients with limb ischemia and in
contrast to lower extremity, atherosclerosis is not a major
contributor to upper extremity ischemia<span class="citation"><sup>[<a href="#ref-shuja117UpperExtremity" role="doc-biblioref">90</a>]</sup></span></p></li>
<li><p>Vast majority of cases caused by autoimmune/connective tissue
disorders</p></li>
</ul>
<p><strong>How can upper extremity disease be classified?</strong></p>
<p>Anatomic Location:</p>
<ul>
<li>Large vs. Small Vessel</li>
</ul>
<p>Disease Process:</p>
<ul>
<li>Vaso-occlusive disease often requires endovascular/surgical
management.</li>
<li>Vasospastic disease is more responsive to pharmacological
management.</li>
</ul>
</div>
<div id="evaluation" class="section level3 hasAnchor" number="3.1.3">
<h3><span class="header-section-number">3.1.3</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>How should patients be evaluated who have concern for upper extremity
disease?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Detailed H+P evaluation (pulse palpation, auscultation at
supraclavicular/infraclavicular fossa may reveal a bruit concerning
for subclavian artery stenosis, upper extremity neurovascular/skin
exam)</p></li>
<li><p>Brachial/forearm blood pressures and if suspected claudication,
measured at rest and 2-5 minutes after exercise. Look for a gradient
of &gt;20 mmHg is considered significant</p></li>
<li><p>Some or all of 6 P’s of acute limb ischemia with symptoms occurring
within 14 days are deemed acute</p></li>
<li><p>Doppler insonation of radial, ulnar, palmar, and digital arteries</p></li>
<li><p>Vascular Lab Evaluation</p>
<ol style="list-style-type: decimal">
<li><p>Segmental Pressure Measurements</p></li>
<li><p>Duplex Ultrasound (look for large vessel occlusive disease)</p></li>
</ol></li>
<li><p>Other Imaging</p>
<ol style="list-style-type: decimal">
<li>CTA/MRA</li>
</ol></li>
<li><p>Clinical Lab tests</p>
<ol style="list-style-type: decimal">
<li><p>Inflammatory disorders-CBC, ESR, ANA, RF</p></li>
<li><p>Hypercoagulable screening</p></li>
</ol></li>
</ol>
</div>
</div>
<div id="vaso-occlusive-disease" class="section level2 hasAnchor" number="3.2">
<h2><span class="header-section-number">3.2</span> Vaso-occlusive Disease<a href="upper-extremity-and-thoracic-outlet.html#vaso-occlusive-disease" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<div id="acute-limb-ischemia" class="section level3 hasAnchor" number="3.2.1">
<h3><span class="header-section-number">3.2.1</span> Acute Limb Ischemia<a href="upper-extremity-and-thoracic-outlet.html#acute-limb-ischemia" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What is the procedure of choice in acute limb ischemia of the upper
extremity?</strong></p>
<p>With acute presentation of upper limb ischemia and a localizing
examination, may be reasonable to proceed directly to OR for embolectomy
to minimize ischemia time.<span class="citation"><sup>[<a href="#ref-wahlberg2006" role="doc-biblioref">91</a>,<a href="#ref-henke2009" role="doc-biblioref">92</a>]</sup></span></p>
<p><strong>What are some postoperative complications of an embolectomy for acute
limb ischemia?</strong></p>
<p>Brachial sheath hematoma - parasthesias and weakness in the median nerve
distribution require emergent re-exploration and decompression. Even
small hematomas that are not readily identifiable on clinical exam, can
cause compression on the median nerve and are a surgical
emergency.<span class="citation"><sup>[<a href="#ref-tran2011" role="doc-biblioref">93</a>]</sup></span></p>
<p>Compartment Syndrome - If prolonged ischemia or no hematoma found, and
forearm compartments appear tense, then should proceed with fasciotomies
to treat forearm compartment syndrome. Rarely performed prophylactically
due to significant morbidity.<span class="citation"><sup>[<a href="#ref-gelberman1981" role="doc-biblioref">94</a>–<a href="#ref-leversedge2011" role="doc-biblioref">96</a>]</sup></span></p>
<ul>
<li><p>Three compartments - forearm volar (flexor, superficial, and deep),
mobile wad (lateral), and dorsal (extensor, superficial, and deep).
Volar compartments most susceptible to ischemia and compartment
syndrome, most vulnerable muscle are flexor digitorum profundas and
flexor pollicus longus.<span class="citation"><sup>[<a href="#ref-ronel2004" role="doc-biblioref">97</a>]</sup></span></p></li>
<li><p>Volar/Henry approach decompresses lateral and volar compartments
with a single incision, includes carpal tunnel release.</p></li>
</ul>
</div>
<div id="chronic-limb-threatening-ischemia" class="section level3 hasAnchor" number="3.2.2">
<h3><span class="header-section-number">3.2.2</span> Chronic Limb Threatening Ischemia<a href="upper-extremity-and-thoracic-outlet.html#chronic-limb-threatening-ischemia" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="demographics-and-presentation---by-anatomic-level" class="section level4 hasAnchor" number="3.2.2.1">
<h4><span class="header-section-number">3.2.2.1</span> Demographics and Presentation - by anatomic level<a href="upper-extremity-and-thoracic-outlet.html#demographics-and-presentation---by-anatomic-level" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p><strong>What are causes and symptoms associated with subclavian/axillary
occlusive disease?</strong><span class="citation"><sup>[<a href="#ref-jacklcronenwettVascularDecisionMaking2020" role="doc-biblioref">98</a>]</sup></span></p>
<ul>
<li><p>Etiology: Atherosclerosis is the most common cause of
subclavian/axillary occlusive disease. Left SCA &gt; Right
involvement. Less common causes include Takayasu disease, giant cell
arteritis, or arterial TOS</p></li>
<li><p>Symptoms: Upper extremity arm/hand ischemia or neurologic symptoms
due to subclavian-vertebral steal. Because significant collaterals,
minimal pain on exertion even with subclavian occlusion</p></li>
<li><p>Innominate disease can present with complex steal syndrome from the
vertebral artery.<span class="citation"><sup>[<a href="#ref-rodriguez2016" role="doc-biblioref">99</a>]</sup></span></p></li>
</ul>
<p><strong>What are causes and symptoms associated with brachial/forearm
occlusive disease?</strong></p>
<ul>
<li><p>Etiology: MCC of brachial artery occlusion is cardiac origin
embolus. Atherosclerosis RARELY affects the brachial artery. Distal
axillary/proximal brachial stenosis can be from repetitive trauma
from crutch use.</p>
<ul>
<li>Radiation arteritis - may be seen with radiation after breast
cancer therapy. Lesions characteristically tapered with smooth
border. May occur alongside a brachial
plexopathy.<span class="citation"><sup>[<a href="#ref-goldstein2010" role="doc-biblioref">100</a>,<a href="#ref-modrall2003" role="doc-biblioref">101</a>]</sup></span></li>
</ul></li>
<li><p>Forearm occlusive disease can be seen in advanced ESRD/DM where
calcific atherosclerosis of radial/ulnar arteries is present. Less
common causes include Buerger’as disease or Raynaud Phenomenon</p></li>
</ul>
</div>
<div id="management-1" class="section level4 hasAnchor" number="3.2.2.2">
<h4><span class="header-section-number">3.2.2.2</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-1" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p><strong>How/when is upper extremity occlusive disease treated?</strong></p>
<p>Indications for treatment</p>
<ul>
<li><p>70% stenosis and associated symptoms or deficit</p></li>
<li><p>Lesion with ipsilateral ICA requiring treatment</p></li>
<li><p>Pre-occlusive lesion in a good surgical candidate (&gt;5y life
expectancy)</p></li>
</ul>
<p>Innominate or SCA Occlusive Disease</p>
<ul>
<li><p>Endovascular with balloon expandable stent via femoral or
ipsilateral brachial artery.<span class="citation"><sup>[<a href="#ref-chatterjeeAngioplastyAloneAngioplasty2013" role="doc-biblioref">102</a>–<a href="#ref-mordasini2011" role="doc-biblioref">106</a>]</sup></span>
Preferred in:</p>
<ul>
<li><p>Short segment or ostial disease with adequate distance to the
vertebral artery origin.</p></li>
<li><p>History of neck surgery or radiation.</p></li>
</ul></li>
<li><p>Surgery:</p>
<ul>
<li><p>Bypass from aortic arch through median sternotomy - Most durable
option, particularly for dense R innominate disease, so
preferred in patients who can tolerate. Endarterectomy not
appropriate if disease involves the origin.<span class="citation"><sup>[<a href="#ref-berguer1998" role="doc-biblioref">63</a>,<a href="#ref-aiello2011" role="doc-biblioref">107</a>–<a href="#ref-byrne2007" role="doc-biblioref">112</a>]</sup></span></p>
<ul>
<li>Complications include compression of the graft on sternal
closure, so proximal anastomosis should be placed to the
side of the aorta.</li>
</ul></li>
<li><p>Ipsilateral CCA to subclavian artery (bypass or transposition) -
Recent NSQIP study showed no difference in stroke and death for
CS bypass vs transposition, therefore procedure should be
determined by anatomic constraints.<span class="citation"><sup>[<a href="#ref-cinà2002" role="doc-biblioref">113</a>,<a href="#ref-vandervliet1995" role="doc-biblioref">114</a>]</sup></span>
Small studies and systematic reviews have shown that patency of
carotid subclavian bypass is better with synthetic graft than
with autologous vein.<span class="citation"><sup>[<a href="#ref-aburahma2000" role="doc-biblioref">115</a>–<a href="#ref-ziomek1986" role="doc-biblioref">117</a>]</sup></span></p>
<ul>
<li><p>An additional indication for carotid subclavian bypass is as
a staged revascularization prior to TEVAR for aneurysmal
disease requiring coverage of the LSA</p></li>
<li><p><strong>How does the exposure differentiate in transposition vs
bypass?</strong></p>
<ul>
<li><p>Arterial transposition via a short, transverse cervical
incision above the clavicle between two heads of SCM
(bypass is lateral to entire SCM)</p></li>
<li><p>Sub-platysmal flaps created and avoid EJ vein damage</p></li>
<li><p>Omohypoid divided between heads of SCM and IJ mobilized
laterally (bypass IJ is mobilized medially to expose CCA
and care must be taken to avoid phrenic nerve in more
lateral approach)</p></li>
<li><p>CCA is reflected medially with vagus nerve</p></li>
<li><p>On the left side, the thoracic duct is identifiable and
divided followed by dividing the vertebral vein</p></li>
<li><p>Subclavian artery and proximal branches identified
(anterior scalene is in lateral dissection)</p></li>
</ul></li>
<li><p><strong>What are some common complications after carotid
subclavian bypass in order of highest to lowest incidence?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Phrenic nerve palsy (most common) - most often managed
conservatively.</p></li>
<li><p>Recurrent laryngeal palsy</p></li>
<li><p>Lymphatic leak</p></li>
<li><p>Neck hematoma<span class="citation"><sup>[<a href="#ref-voigtOutcomesCarotidsubclavianBypass2019" role="doc-biblioref">118</a>]</sup></span></p></li>
</ol></li>
<li><p><strong>When carotid-subclavian bypass compared to
transposition?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Vertebral artery takes origin from the subclavian artery
in a very proximal position or is dominant over the
contralateral side, then bypass preferred.<span class="citation"><sup>[<a href="#ref-moraschTechniqueSubclavianCarotid2009d" role="doc-biblioref">119</a>]</sup></span></p></li>
<li><p>For coronary-subclavian steal with patent internal
mammary artery to coronary artery bypass graft, then
Bypass (a carotid-subclavian transposition requires a
more proximal clamp with occlusion of inline antegrade
flow to the coronary bypass during the procedure)<span class="citation"><sup>[<a href="#ref-cuaReviewCoronarySubclavian2017" role="doc-biblioref">120</a>]</sup></span></p></li>
</ol></li>
</ul></li>
<li><p>Contralateral CCA (anterior or retropharyngeal)</p></li>
</ul></li>
</ul>
<p>Brachial/forearm Occlusive disease</p>
<ul>
<li><p>Endovascular: PTA evidence is anecdotal with stents for lesions
unresponsive to PTA or dissection following angioplasty.<span class="citation"><sup>[<a href="#ref-cheun2019" role="doc-biblioref">121</a>–<a href="#ref-dineen2007" role="doc-biblioref">123</a>]</sup></span></p></li>
<li><p>Surgery: GSV vein bypass remains standard for revascularization with
bypasses to superficial or deep palmar arch have good patency rates.
Tunneling is subcutaneous if to distal ulnar or superficial palmar
arch whereas anatomical to distal radial artery over the anatomic
snuffbox.<span class="citation"><sup>[<a href="#ref-chang2003" role="doc-biblioref">124</a>–<a href="#ref-spinelli2010" role="doc-biblioref">126</a>]</sup></span></p></li>
</ul>
</div>
</div>
</div>
<div id="vasospastic-disorders" class="section level2 hasAnchor" number="3.3">
<h2><span class="header-section-number">3.3</span> Vasospastic Disorders<a href="upper-extremity-and-thoracic-outlet.html#vasospastic-disorders" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<div id="iatrogenic-or-vasopressor-induced-ischemia" class="section level3 hasAnchor" number="3.3.1">
<h3><span class="header-section-number">3.3.1</span> Iatrogenic or Vasopressor Induced Ischemia<a href="upper-extremity-and-thoracic-outlet.html#iatrogenic-or-vasopressor-induced-ischemia" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>You are called to the intensive care unit for a septic patient with
acute bilateral upper limb ischemia, what is the management strategy?</strong></p>
<p>Critically ill patients on vasopressors with bilateral upper extremity
ischemia are often managed best with supportive measures and attempts to
wean vasopressors (especially norepinephrine).<span class="citation"><sup>[<a href="#ref-landry2018" role="doc-biblioref">127</a>]</sup></span></p>
<p>Limited role for radial artery embolectomy, only in clear ischemia
isolated to the distribution of an occluded radial artery, often
secondary to line placement.<span class="citation"><sup>[<a href="#ref-valentine2005" role="doc-biblioref">128</a>]</sup></span></p>
</div>
<div id="raynauds-phenomenon" class="section level3 hasAnchor" number="3.3.2">
<h3><span class="header-section-number">3.3.2</span> Raynaud’s Phenomenon<a href="upper-extremity-and-thoracic-outlet.html#raynauds-phenomenon" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What is Raynaud’s and what causes it?</strong><span class="citation"><sup>[<a href="#ref-shuja117UpperExtremity" role="doc-biblioref">90</a>,<a href="#ref-landry141RaynaudPhenomenon2019" role="doc-biblioref">129</a>]</sup></span></p>
<p>Exaggeration of normal physiologic response with episodic pallor or
cyanosis of the fingers caused by small digital artery vasoconstriction
occurring in response to cold or emotional stress. There is an
abnormality with sympathetic nervous system, resulting in a
multifactorial problem involving a combination of vascular, neural, and
humoral factors.</p>
<p><strong>What are the subtypes of Raynaud’s phenomenon and what is the
underlying pathology?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Primary: Raynaud’s disease-idiopathic form that is a benign process
not associated with structural vascular change. Triggers include
(cold, emotional stress, caffeine) resulting in digital smooth
muscle contraction and temporary digital hypoperfusion.</p></li>
<li><p>Secondary: Fixed vascular obstruction to blood flow decreasing
threshold for cold induced vasospasm or progress to tissue loss.
Diseases associated include mixed connective tissue disease, SLE,
and rheumatoid arthritis, and scleroderma (accounts for 80-90% of
cases). In setting of lower digital blood pressure, symptomatic
digital ischemia or tissue loss under low stress conditions. With
cold/emotional stress, vasoconstrictive response of digital artery
smooth muscle further causes arterial closure and resultant symptoms</p></li>
</ol>
<p><strong>What are diagnostic criteria for Raynaud’s?</strong></p>
<ul>
<li><p>Clinical (Progression of ischemia with white -&gt; blue -&gt; red finger
discoloration. Episodes can be self-limited and may last from less
than a minute, but generally not longer than 10-20 minutes</p></li>
<li><p>Qualitative testing for severity of cold sensitivity in Raynaud’s
syndrome can be useful. Most basic test is cold sensitivity and
recovery after ice water immersion. &gt;10 minutes return to baseline
pressure concerning for Raynaud’s</p></li>
<li><p>Segmental pressures with finger systolic blood pressure can
differentiate purely vasospastic vs occlusive disease. Difference of
more than 15 mm Hg between fingers or absolute finger pressure &lt;70
mm Hg may indicate occlusive disease</p></li>
<li><p>Serologic evaluation (ANA/RF)</p></li>
</ul>
<p><strong>What are appropriate treatments for Raynaud’s phenomenon?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Medical-cold/tobacco avoidance lead to improvement in around half of
patients. Calcium channel blocker (nifedipine ER 30mg qday) and
losartan (50mg BID) have been shown to be most
effective.<span class="citation"><sup>[<a href="#ref-landry2013" role="doc-biblioref">130</a>,<a href="#ref-wigley2016" role="doc-biblioref">131</a>]</sup></span> Other drugs include alpha
blocker, sildenafil, fluoxetine (SSRI), reserpine, cilostazol,
captopril.</p>
<ul>
<li>OUTCOMES ARE POOR IN PATIENTS WITH ARTERIAL OBSTRUCTION. If
there is an asymmetric vascular examination, then further
non-invasive vascular imaging is needed.</li>
</ul></li>
<li><p>Surgical-thoracic sympathectomy (used for treatment of digital
artery vasospasm/digital ischemic ulceration). For vasospasm,
thoracic sympathectomy is initially successful, but symptoms return
generally within 3-6 months.</p></li>
<li><p>Immunosuppression/immunomodulation for connective tissue disorders
associated with secondary Raynaud phenomenon</p></li>
</ol>
<p>See Landry’s Review in JVS for a good treatment algorithm.<span class="citation"><sup>[<a href="#ref-landry2013" role="doc-biblioref">130</a>]</sup></span></p>
</div>
<div id="ergotism" class="section level3 hasAnchor" number="3.3.3">
<h3><span class="header-section-number">3.3.3</span> Ergotism<a href="upper-extremity-and-thoracic-outlet.html#ergotism" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What is Ergotism?</strong><span class="citation"><sup>[<a href="#ref-jamescstanleyCurrentTherapyVascular2014" role="doc-biblioref">132</a>]</sup></span></p>
<ul>
<li><p>Etiology: Ergot is a parasitic fungal disease that has a particular
prevalence for infecting rye plants and ergot alkaloids have been
linked to epidemic poisonings that manifested as ergotism from
consumption of rye</p></li>
<li><p>Modern day is rare</p></li>
</ul>
<p><strong>What causes Ergotism and how do patients present?</strong></p>
<ul>
<li><p>Ergotamine is chemically like endogenous catecholamines/indolamines
and when applied clinically, it behaves as an agonist to
alpha-adrenergic, sertoninergic, and dopaminergic receptors. Despite
limited bioavailability, vasocontrictive effects have been reported
to last for 24 hours or longer</p></li>
<li><p>Gangrenous-mild limb pain followed by burning pain/shooting and</p></li>
<li><p>Convulsive-heaviness in limbs and head associated with diarrhea.
Could result in tonic-clonic spasms</p></li>
</ul>
<p><strong>How can you diagnose Ergotism and what is the process for treating
this disease?</strong></p>
<p>Upper extremity ischemia (i.e. digital ulceration) in the setting of
ergot alkaloid use (typically for migraines). The treatment includes:</p>
<ul>
<li><p>Volume expansion and IV heparin as anticoagulation</p></li>
<li><p>IV infusion of nitroprusside, nitroglycerin, iloprost or combination</p></li>
<li><p>Infusion of Ca 2+ channel blockers</p></li>
<li><p>Surgical: for thrombosis, consider thrombolysis</p></li>
</ul>
</div>
<div id="buergers-disease" class="section level3 hasAnchor" number="3.3.4">
<h3><span class="header-section-number">3.3.4</span> Buerger’s Disease<a href="upper-extremity-and-thoracic-outlet.html#buergers-disease" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>How is Buerger’s disease categorized?</strong></p>
<p>Non-atherosclerotic, segmental, inflammatory disease of small/medium
sized arteries in distal extremities of tobacco users distinct from
either atherosclerosis of immune
arteritis<span class="citation"><sup>[<a href="#ref-jacklcronenwettVascularDecisionMaking2020" role="doc-biblioref">98</a>,<a href="#ref-lejoncour2018" role="doc-biblioref">133</a>]</sup></span></p>
<p><strong>What clinical criteria can help diagnose Buerger’s?</strong></p>
<p>Smoking history, onset before 50 years, infrapopliteal arterial
occlusions, upper limb involvement, absence of atherosclerotic risk
factors besides smoking</p>
<p><strong>What is important about diagnosing Buerger’s</strong></p>
<ul>
<li><p>Typically a diagnosis of exclusion</p></li>
<li><p>Must rule out proximal embolic source, trauma, local lesions (e.g.
pop entrapment or cystic adventitial disease), autoimmune disease,
hypercoagulable status, atherosclerosis</p></li>
</ul>
<p><strong>What physical exam and non-invasive/invasive imaging findings of
Buerger’s?</strong></p>
<ul>
<li><p>Distal, but not proximal arterial disease (palpable
brachial/popliteal but absent/reduced at ankle or wrist)</p></li>
<li><p>DBI&lt;0.6 and flat/reduced digital waveforms</p></li>
<li><p>CTA/MRA/DSA or duplex - characteristic findings of
serpiginous/corkscrew collaterals, occlusion of distal calf/pedal
arteries, and normal proximal arteries.<span class="citation"><sup>[<a href="#ref-busch2011" role="doc-biblioref">134</a>,<a href="#ref-fujii2011" role="doc-biblioref">135</a>]</sup></span></p></li>
</ul>
<p><strong>What is the mainstay treatment in Buerger’s disease?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Smoking cessation! Only treatment to improve symptoms and reduce
amputation risk if achieved before onset of gangrene or tissue loss.
Important to remember following treatments will likely fail without
smoking cessation.</p></li>
<li><p>If smoking cessation does not improve, medical management with
antiplatelet agents, immunomodulators, vasodilators, anticoagulants</p></li>
<li><p>Endovascular-distal small vessel intervention</p></li>
<li><p>Surgical-upper extremity autogenous vein bypass-limited success due
to poor outflow</p></li>
<li><p>Sometimes can consider upper extremity sympathectomy, but unproven
benefit</p></li>
<li><p>Amputation-reported in 30-40% who are followed longer than 5
years<span class="citation"><sup>[<a href="#ref-olin2018" role="doc-biblioref">136</a>]</sup></span></p></li>
</ol>
</div>
<div id="large-vasculitis" class="section level3 hasAnchor" number="3.3.5">
<h3><span class="header-section-number">3.3.5</span> Large Artery Vasculitis<a href="upper-extremity-and-thoracic-outlet.html#large-vasculitis" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What are common characteristics for patients who are suspected to have
a large vessel vasculitis?</strong><span class="citation"><sup>[<a href="#ref-shanmugam137VasculitisOther2019" role="doc-biblioref">137</a>,<a href="#ref-weyand2003" role="doc-biblioref">138</a>]</sup></span></p>
<ul>
<li><p>Affect aorta and major branches</p></li>
<li><p>Present with non-specific heterogenous symptoms making the diagnosis
challenging. Most commonly, they present with systemic or
constitutional symptoms (fatigue, fever, weight loss, arthralgias)</p></li>
<li><p>Frequently, diagnosis made with presence of constitutional symptoms,
elevated inflammatory markers, and dedicated imaging (MRA, CTA, DUS,
or PET)</p></li>
</ul>
<p><strong>How can you differentiate Takayasu arteritis vs giant cell
arteritis?</strong></p>
<div id="takayasu-arteritis" class="section level4 hasAnchor" number="3.3.5.1">
<h4><span class="header-section-number">3.3.5.1</span> Takayasu arteritis<a href="upper-extremity-and-thoracic-outlet.html#takayasu-arteritis" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ol style="list-style-type: decimal">
<li><p>Aorta and primary<span class="citation"><sup>[<a href="#ref-ehlert2019" role="doc-biblioref">139</a>]</sup></span></p></li>
<li><p>Young patients &lt;20 years and female in 80-90% of cases, Asian
populations</p></li>
<li><p>Criteria (ACR)</p>
<ol style="list-style-type: decimal">
<li><p>Onset &lt;40 years</p></li>
<li><p>Claudication of an extremity</p></li>
<li><p>Decreased brachial pulse</p></li>
<li><p>&gt;10 mmHg SBP between arms</p></li>
<li><p>Bruit over subclavian arteries or aorta</p></li>
<li><p>Arteriographic evidence of narrowing/occlusion in aorta/primary
branches/or large upper/lower extremity arteries</p></li>
</ol></li>
<li><p>Initial therapy for acute vasculitis should include steroids and
close observation. If persistent severe symptoms after acute phase,
then consider surgical repair. Mid aortic syndrome likely needs open
repair from uninvolved aorta-usually thoracic aorta-to bifurcation
bypass with jump graft to involved visceral vessels.<span class="citation"><sup>[<a href="#ref-ehlert2019" role="doc-biblioref">139</a>]</sup></span></p></li>
</ol>
</div>
<div id="giant-cell-arteritis" class="section level4 hasAnchor" number="3.3.5.2">
<h4><span class="header-section-number">3.3.5.2</span> Giant cell arteritis<a href="upper-extremity-and-thoracic-outlet.html#giant-cell-arteritis" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ol style="list-style-type: decimal">
<li><p>Aorta and main branches, but predilection for carotid artery
branches<span class="citation"><sup>[<a href="#ref-bongartz2006" role="doc-biblioref">140</a>]</sup></span></p></li>
<li><p>Diagnosis:</p>
<ol style="list-style-type: decimal">
<li><p>Age at disease onset &gt; 50 years</p></li>
<li><p>New headache</p></li>
<li><p>Temporal artery abnormality</p></li>
<li><p>Elevated ESR (&gt;50) - can be normal in up to a quarter of cases.</p></li>
<li><p>Abnormal artery biopsy (gold standard test)</p></li>
</ol></li>
<li><p>Other symptoms include jaw pain with mastication or visual changes</p></li>
<li><p>Associated with Polymyalgia rheumatic, characterized by morning
stiffness in shoulders/hips occurring in 40-50% of patients</p></li>
<li><p>Arteriography/MRA/CTA/PET may be used to assess large vessel
involvement - classic finding is smooth, tapering stenosis.</p></li>
</ol>
<p><strong>How should patients be monitored with active large artery
vasculitis?</strong></p>
<ul>
<li><p>Lab data tracked at least monthly for 6 months with close follow-up
to ensure appropriate response to medical treatment and enable
physicians to assess for adverse effects of medical treatment</p></li>
<li><p>Repeat tests after remission reached and imaging choice to evaluate
large vessels (DUS/CTA/MRA)</p></li>
</ul>
<p><strong>What is the medical treatment for GCA and when do you consider
surgical treatment?</strong></p>
<ul>
<li><p>Medical-steroid therapy. In as many as 50% of patients who have a
large vessel vasculitis refractory to glucocorticoid therapy alone,
patients will trial immunomodulators or cytotoxic trugs (i.e.
methotrexate, azathioprine, mycophenolate, tocilizumab, or
leflunomide)</p></li>
<li><p>Intervention-once remission, treatment of symptomatic arterial
lesions or those at aneurysm size threshold should be considered and
as many as 50-70% with large vessel vasculitis will require
intervention.</p>
<ul>
<li><p>Endovascular-angioplasty/stent/stent graft for large vessel
vasculitis have all been described, however higher restenosis in
endovascular compared to open treatment</p></li>
<li><p>Open Surgery (gold standard)-lesions are long, fibrotic and
therefore less amenable to endovascular treatment. Bypass grafts
from aorta-CCA are the most common (CEA should be avoid due to
pathology involved)</p>
<ul>
<li><p>Upper extremity bypass with autogenous vein to the brachial
artery</p></li>
<li><p>Aortic aneurysms should be managed with open
surgery<span class="citation"><sup>[<a href="#ref-janssen2008" role="doc-biblioref">141</a>]</sup></span></p></li>
</ul></li>
</ul></li>
</ul>
</div>
</div>
<div id="other-vasculitis-syndromes" class="section level3 hasAnchor" number="3.3.6">
<h3><span class="header-section-number">3.3.6</span> Other Vasculitis syndromes<a href="upper-extremity-and-thoracic-outlet.html#other-vasculitis-syndromes" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Polyarteritis Nodosum - Focal necrotizing lesions primarily affecting
medium-sized muscular arteries, peak incidence in 40s.  Multiple
saccular aneurysms secondary to inflammatory destruction of vessel
media.<span class="citation"><sup>[<a href="#ref-weyand2003" role="doc-biblioref">138</a>,<a href="#ref-shanmugam2019" role="doc-biblioref">142</a>]</sup></span></p>
<p>Behçet Disease - recurrent oral pathos ulcers, genital ulcers and
uveitis.<span class="citation"><sup>[<a href="#ref-weyand2003" role="doc-biblioref">138</a>,<a href="#ref-shanmugam2019" role="doc-biblioref">142</a>]</sup></span></p>
</div>
</div>
<div id="aneurysmal-disease" class="section level2 hasAnchor" number="3.4">
<h2><span class="header-section-number">3.4</span> Aneurysmal Disease<a href="upper-extremity-and-thoracic-outlet.html#aneurysmal-disease" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<div id="subclavian-artery-aneurysms" class="section level3 hasAnchor" number="3.4.1">
<h3><span class="header-section-number">3.4.1</span> Subclavian Artery Aneurysms<a href="upper-extremity-and-thoracic-outlet.html#subclavian-artery-aneurysms" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>How are subclavian aneurysms caused and how can they present?</strong><span class="citation"><sup>[<a href="#ref-baig84UpperExtremity2019" role="doc-biblioref">143</a>]</sup></span></p>
<div id="etiology" class="section level4 hasAnchor" number="3.4.1.1">
<h4><span class="header-section-number">3.4.1.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Degenerative - atherosclerotic or due to aberrant right subclavian
with degenerative changes in proximal subclavian known as “Kommerell
diverticulum”</p></li>
<li><p>Traumatic - blunt, penetrating, iatrogenic with attempted catheter
placement</p></li>
<li><p>Radiation induced, sometimes seen after radiation for breast
cancer.<span class="citation"><sup>[<a href="#ref-mohan2016" role="doc-biblioref">144</a>]</sup></span></p></li>
<li><p>Thoracic outlet obstruction - no need to investigate for aTOS if
there is another plausible cause.</p></li>
</ul>
</div>
<div id="presentation" class="section level4 hasAnchor" number="3.4.1.2">
<h4><span class="header-section-number">3.4.1.2</span> Presentation<a href="upper-extremity-and-thoracic-outlet.html#presentation" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li>Rare, comprises 1% of peripheral aneurysms.</li>
<li>Exam-pulsatile supraclavicular mass or bruit, absent/diminished
pulses, signs of microembolization (“blue finger”)</li>
<li>Most discovered incidentally, however referred chest, neck, shoulder
pain, upper extremity ischemia due to thrombosis or distal embolism,
brachial plexus compression, hoarseness from right recurrent
laryngeal nerve compression</li>
<li>Dysphagia from esophageal compression in aberrant right subclavian
artery</li>
<li>Rarely rupture</li>
</ul>
</div>
<div id="evaluation-1" class="section level4 hasAnchor" number="3.4.1.3">
<h4><span class="header-section-number">3.4.1.3</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-1" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p><strong>What are diagnostic studies and treatment modalities for subclavian
aneurysms?</strong></p>
<ul>
<li><p>CXR-mediastinal mass may suggest neoplasm</p></li>
<li><p>MRA/CTA important to delineate extent of aneurysm and proximity to
ipsilateral vertebral artery</p></li>
</ul>
</div>
<div id="management-2" class="section level4 hasAnchor" number="3.4.1.4">
<h4><span class="header-section-number">3.4.1.4</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-2" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Open Repair-resection/endoaneurysmorrhaphy with end to end (small
aneurysms) or interposition prosthetic graft<span class="citation"><sup>[<a href="#ref-vierhout2010" role="doc-biblioref">145</a>]</sup></span></p>
<ul>
<li><p>Proximal-median sternotomy with supraclavicular fossa extension
for adequate proximal control for right side, however
supraclavicular with left anterolateral thoracotomy for left
subclavian aneurysm</p></li>
<li><p>Mid-Distal-supraclavicular/infraclavicular generally adequate
for control where again resection of the clavicle may be needed</p></li>
</ul></li>
<li><p>Endovascular Repair-transbrachial/transfemoral approach with covered
stent<span class="citation"><sup>[<a href="#ref-maskanakis2018" role="doc-biblioref">146</a>]</sup></span></p>
<ul>
<li>Must consider vertebral artery origin. Can cover vertebral
artery if contralateral vertebral artery is patent and of
adequate size, however posterior circulation stroke may occur
when the contralateral vertebral artery is highly stenotic,
hypoplastic or occluded.</li>
</ul></li>
<li><p>Hybrid Repair-embolization/coils of proximal subclavian artery
combined with subclavian transposition or carotid-subclavian bypass</p></li>
<li><p>For aberrant subclavian artery aneurysm, resection or exclusion of
the aneurysmal artery with vascular reconstruction of the subclavian
artery is recommended. Especially in the setting of dysphagia
lusoria, subclavian artery reconstructed by interposition graft
where proximal anastomosis is on ascending aorta. Alternatively,
left posterolateral thoracotomy for proximal aneurysm resection and
right supraclavicular incision for reconstruction of subclavian
artery by end to side to the right CCA has been reported.</p></li>
</ul>
</div>
</div>
<div id="axillary-artery-aneurysms" class="section level3 hasAnchor" number="3.4.2">
<h3><span class="header-section-number">3.4.2</span> Axillary Artery Aneurysms<a href="upper-extremity-and-thoracic-outlet.html#axillary-artery-aneurysms" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>How are axillary aneurysms caused and how can they present?</strong></p>
<div id="etiology-1" class="section level4 hasAnchor" number="3.4.2.1">
<h4><span class="header-section-number">3.4.2.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology-1" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Blunt/penetrating trauma</p></li>
<li><p>Congenital (infrequently reported)</p></li>
<li><p>Post-traumatic axillary aneurysms (repeated abduction/external
rotation downward toward humeral head in baseball pitchers)</p></li>
</ul>
</div>
<div id="presentation-1" class="section level4 hasAnchor" number="3.4.2.2">
<h4><span class="header-section-number">3.4.2.2</span> Presentation<a href="upper-extremity-and-thoracic-outlet.html#presentation-1" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li>Exam-pulsatile supraclavicular mass or bruit, absent/diminished
pulses, signs of microembolization (“blue finger”)</li>
</ul>
<p><strong>What are diagnostic studies and treatment modalities for axillary
aneurysms?</strong></p>
</div>
<div id="evaluation-2" class="section level4 hasAnchor" number="3.4.2.3">
<h4><span class="header-section-number">3.4.2.3</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-2" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Ultrasound</p></li>
<li><p>CTA/MRA of upper extremity</p></li>
</ul>
</div>
<div id="management-3" class="section level4 hasAnchor" number="3.4.2.4">
<h4><span class="header-section-number">3.4.2.4</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-3" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Open Repair-resection with interposition vein grafting or prosthetic
if inadequate vein is present.</p></li>
<li><p>Endovascular repair-covered stent graft can be placed with
occasional embolization with micro coils to isolate sac and prevent
retrograde endoleaks</p></li>
</ul>
</div>
</div>
<div id="brachial-artery-aneurysms" class="section level3 hasAnchor" number="3.4.3">
<h3><span class="header-section-number">3.4.3</span> Brachial Artery Aneurysms<a href="upper-extremity-and-thoracic-outlet.html#brachial-artery-aneurysms" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>How are brachial aneurysms caused and how can they present?</strong></p>
<div id="etiology-2" class="section level4 hasAnchor" number="3.4.3.1">
<h4><span class="header-section-number">3.4.3.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology-2" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>False aneurysms secondary to repetitive trauma</p></li>
<li><p>Iatrogenic complications - Seen in 1-3% of brachial artery access -
increased risk in older age, female patients, and larger
sheaths.<span class="citation"><sup>[<a href="#ref-treitl2015" role="doc-biblioref">147</a>]</sup></span> More on appropriate access technique can be
found in <a href="venous-disease.html#endovascular">9.2.4.3</a></p></li>
<li><p>IV drug abuse (infected pseudoaneurysms in antecubital fossa)</p></li>
<li><p>Connective tissue disorders (ex. type IV Ehlers danlos)</p></li>
</ul>
</div>
<div id="presentation-2" class="section level4 hasAnchor" number="3.4.3.2">
<h4><span class="header-section-number">3.4.3.2</span> Presentation:<a href="upper-extremity-and-thoracic-outlet.html#presentation-2" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Exam: pulsatile mass</p></li>
<li><p>Local pain or symptoms of median nerve compressions</p></li>
<li><p>Hand/digital ischemia from thrombosis/distal embolization</p></li>
</ul>
<p><strong>What are diagnostic studies and treatment modalities for brachial
aneurysms?</strong></p>
</div>
<div id="evaluation-3" class="section level4 hasAnchor" number="3.4.3.3">
<h4><span class="header-section-number">3.4.3.3</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-3" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Duplex Ultrasound</p></li>
<li><p>CTA/MRA of upper extremity may be needed to delineate extent of
aneurysm</p></li>
</ul>
</div>
<div id="management-4" class="section level4 hasAnchor" number="3.4.3.4">
<h4><span class="header-section-number">3.4.3.4</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-4" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Open Repair (preferred)-resection with patch or interposition vein
grafting</p></li>
<li><p>Endovascular repair-rare and generally in a traumatic setting</p></li>
<li><p>Iatrogenic injuries-due to access and nonoperative treatment for
small/asymptomatic pseudoaneurysms that are likely to thrombose
spontaneously. Direct suture repair with evacuation of hematoma is
possible. Thrombin injection is less favorable due to location and
short neck.</p></li>
<li><p>Neurologic symptoms often from median nerve compression an require
urgent repair, open surgery best for decompression.</p></li>
</ul>
</div>
</div>
<div id="radial-artery-pseudoaneurysm" class="section level3 hasAnchor" number="3.4.4">
<h3><span class="header-section-number">3.4.4</span> Radial Artery Pseudoaneurysm<a href="upper-extremity-and-thoracic-outlet.html#radial-artery-pseudoaneurysm" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>How do you manage a patient who presents with a radial artery
pseudoaneurysm after a coronary angiogram on year ago?</strong></p>
<p>Small pseudoaneurysms &lt;3cm have a high rate of spontaneous thrombosis.
However, larger psuedoaneurysms or those with symptoms require
treatment. Often best managed with open excision and primary repair or
interposition graft.<span class="citation"><sup>[<a href="#ref-tosti2017" role="doc-biblioref">148</a>]</sup></span></p>
<p>Can also be seen as a result of trauma.<span class="citation"><sup>[<a href="#ref-bagir2017" role="doc-biblioref">149</a>]</sup></span></p>
</div>
</div>
<div id="occupational-vascular-disease" class="section level2 hasAnchor" number="3.5">
<h2><span class="header-section-number">3.5</span> Occupational Vascular Disease<a href="upper-extremity-and-thoracic-outlet.html#occupational-vascular-disease" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><strong>There are some occupational vascular disorders than contribute to
vascular disease in the upper extremity. Hand arm vibration syndrome and
hypothenar hammer are of particular importance. Can you talk to us about
the key information from these syndromes?</strong><span class="citation"><sup>[<a href="#ref-eskandari185ConditionsArising2020" role="doc-biblioref">150</a>]</sup></span></p>
<div id="hand-arm-vibration-syndrome" class="section level3 hasAnchor" number="3.5.1">
<h3><span class="header-section-number">3.5.1</span> Hand-Arm Vibration Syndrome<a href="upper-extremity-and-thoracic-outlet.html#hand-arm-vibration-syndrome" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="etiology-3" class="section level4 hasAnchor" number="3.5.1.1">
<h4><span class="header-section-number">3.5.1.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology-3" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Vibrating handheld machines (eg pneumatic hammers and drills,
grinders, and chain saws)</p></li>
<li><p>Linear relationship between exposure over years and onset of this
syndrome</p></li>
<li><p>Exact mechanism unknown, but thought that endothelial damage with
sympathetic hyperactivity -&gt; finger blanching attack</p></li>
</ul>
</div>
<div id="presentation-3" class="section level4 hasAnchor" number="3.5.1.2">
<h4><span class="header-section-number">3.5.1.2</span> Presentation<a href="upper-extremity-and-thoracic-outlet.html#presentation-3" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Various stages seen where early results in slight tingling/numbness
and lateral, the tips of one or more fingers experience attacks of
blanching that is usually precipitated by cold</p></li>
<li><p>Blanching typically lasts 1 hour and terminates with reactive
hyperemia, but prolonged exposure can cause bluish black cyanosis of
fingers</p></li>
</ul>
</div>
<div id="evaluation-4" class="section level4 hasAnchor" number="3.5.1.3">
<h4><span class="header-section-number">3.5.1.3</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-4" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Detailed history with use of vibrating tools/symptoms of Raynaud
phenomenon</p></li>
<li><p>Objectively: cold induced ischemia with recording time until digital
temperature recovers</p></li>
<li><p>Digital occlusion with noninvasive digit pressures or duplex
scanning</p></li>
</ul>
</div>
<div id="management-5" class="section level4 hasAnchor" number="3.5.1.4">
<h4><span class="header-section-number">3.5.1.4</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-5" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Avoidance of vibratory tools</p></li>
<li><p>Nifedipine (Ca2+ channel blocker) in advanced cases</p></li>
<li><p>IV prostanoid (ie prostacyclin) for digital gangrene</p></li>
<li><p>Surgery-cervical sympathetectomy or digital sympathectomy rarely
needed<br />
</p></li>
</ul>
</div>
</div>
<div id="hypothenar-hammer-syndrome" class="section level3 hasAnchor" number="3.5.2">
<h3><span class="header-section-number">3.5.2</span> Hypothenar hammer syndrome<a href="upper-extremity-and-thoracic-outlet.html#hypothenar-hammer-syndrome" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="etiology-4" class="section level4 hasAnchor" number="3.5.2.1">
<h4><span class="header-section-number">3.5.2.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology-4" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Repetitive use of palm of hand in activities that involve pushing,
pounding, twisting - particularly to the ulnar artery as it exits
guyots canal and crosses the hook of the hamate.<span class="citation"><sup>[<a href="#ref-ferris2000" role="doc-biblioref">151</a>]</sup></span></p></li>
<li><p>Name comes from reports of mechanics, factory workers, carpenters or
laborers who habitually use there hands as a hammer are ad risk for
disease</p></li>
<li><p>Repetitive trauma leads to thrombotic occlusion, aneurysm formation
or both</p></li>
</ul>
</div>
<div id="presentation-4" class="section level4 hasAnchor" number="3.5.2.2">
<h4><span class="header-section-number">3.5.2.2</span> Presentation<a href="upper-extremity-and-thoracic-outlet.html#presentation-4" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Asymmetrical distribution involving dominant upper extremity where
cyanosis and pallor can occur and digits affected are ulnar
distribution in nature</p></li>
<li><p>Cool/mottled digits or severe cases with ischemic ulcers</p></li>
</ul>
</div>
<div id="evaluation-5" class="section level4 hasAnchor" number="3.5.2.3">
<h4><span class="header-section-number">3.5.2.3</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-5" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Duplex ultrasound</p></li>
<li><p>CTA or MRA</p></li>
<li><p>Arteriography (gold standard) with corkscrew pattern typically in
affected vessels</p></li>
</ul>
</div>
<div id="management-6" class="section level4 hasAnchor" number="3.5.2.4">
<h4><span class="header-section-number">3.5.2.4</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-6" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Conservative-smoking cessation/hand protection/cold
avoidance.<span class="citation"><sup>[<a href="#ref-carr2019" role="doc-biblioref">152</a>]</sup></span></p></li>
<li><p>Medical-calcium channel blockers/antiplatelet</p></li>
<li><p>Surgical (severe digital ischemia/aneurysm)-ligation if adequate
collateral or interposition vein graft has good long term patency.</p></li>
</ul>
</div>
</div>
<div id="environmental-exposures" class="section level3 hasAnchor" number="3.5.3">
<h3><span class="header-section-number">3.5.3</span> Environmental Exposures<a href="upper-extremity-and-thoracic-outlet.html#environmental-exposures" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>Exposure to what environmental agents can result in upper extremity
ischemia?</strong></p>
<p>Acrosteolysis</p>
<ul>
<li><p>Exposure to polyvinyl chloride can result in ischemic hand symptoms
similar to those of Raynaud syndrome</p></li>
<li><p>Angiography-damage to digital arteries with multiple
stenosis/occlusions or hyper vascularity adjacent to areas of bone
resorption</p></li>
<li><p>Treatment-supportive</p></li>
</ul>
<p>Electrical burns</p>
<ul>
<li><p>&lt;1000 V cause injuries limited to immediate skin/soft tissue,
however &gt;1000 V cause damage from entry to exit point</p></li>
<li><p>Results in arterial necrosis with thrombus or bleeding and gangrene
of digits develop</p></li>
<li><p>Initially can be occlusion/thrombosis or spasm, however later damage
can cause aneurysmal degeneration</p></li>
<li><p>Treatment-dependent on soft tissue/bone injuries as well. Can have
reconstruction with free flap due to local vascular damage or
occlusion of major artery requiring bypass grafting</p></li>
</ul>
<p>Extreme thermal injuries</p>
<ul>
<li><p>Workers at risk with chronic exposure to cold (slaughterhouse,
canning factory, and fisheries)</p></li>
<li><p>Raynaud syndrome symptoms due to vasomotor disturbances in the hands
when exposed to extreme chronic thermal trauma</p></li>
<li><p>Treatment-Supportive</p></li>
</ul>
</div>
<div id="sports-medicine" class="section level3 hasAnchor" number="3.5.4">
<h3><span class="header-section-number">3.5.4</span> Sports Medicine<a href="upper-extremity-and-thoracic-outlet.html#sports-medicine" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>How can athletes specifically be affected by upper extremity
ischemia?</strong></p>
<p>Athletes who engage in strenuous or exaggerated hand/shoulder activity
may be susceptible to upper extremity ischemia from arterial injury
manifested by Raynaud syndrome, symptoms of sudden arterial occlusion or
digital embolization</p>
</div>
</div>
<div id="vascular-trauma-upper-extremity" class="section level2 hasAnchor" number="3.6">
<h2><span class="header-section-number">3.6</span> Vascular Trauma-Upper Extremity<a href="upper-extremity-and-thoracic-outlet.html#vascular-trauma-upper-extremity" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><strong>This is discussed in detail here:</strong> <a href="vascular-trauma.html#peripheral">10.1</a>, <strong>so we will go
over some important specifics for upper extremity vascular injury.</strong><span class="citation"><sup>[<a href="#ref-kauvar184VascularTrauma2020" role="doc-biblioref">153</a>]</sup></span></p>
<div id="subclavian-artery-trauma" class="section level3 hasAnchor" number="3.6.1">
<h3><span class="header-section-number">3.6.1</span> Subclavian Artery Trauma<a href="upper-extremity-and-thoracic-outlet.html#subclavian-artery-trauma" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What is the management strategy for an iatrogenic placement of a
subclavian artery catheter?</strong></p>
<p>Critically ill patients can be treated effectively with the use of a
closure device or covered stent placement.<span class="citation"><sup>[<a href="#ref-yoon2015" role="doc-biblioref">154</a>–<a href="#ref-cohen2014" role="doc-biblioref">156</a>]</sup></span> Cut down in the mid subclavian artery is very difficult to
perform and results in increased blood loss and worse outcomes.</p>
<p>Trauma to the proximal subclavian should be accessed on R through a
median sternotomy or trapdoor incision. On the left, the proximal
subclavian is accessed best through an anterolateral thoracotomy. For
more on exposures, see <a href="vascular-lab.html#upper-extremity">12.4</a>.</p>
</div>
<div id="axillary-artery-trauma" class="section level3 hasAnchor" number="3.6.2">
<h3><span class="header-section-number">3.6.2</span> Axillary Artery Trauma<a href="upper-extremity-and-thoracic-outlet.html#axillary-artery-trauma" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What is the mechanism and management of upper extremity axillary
artery trauma?</strong></p>
<div id="etiology-5" class="section level4 hasAnchor" number="3.6.2.1">
<h4><span class="header-section-number">3.6.2.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology-5" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li>Predominantly in penetrating trauma with equal incidence in
proximal/middle/distal divisions and brachial plexus injury in
&gt;1/3rd of arterial injury</li>
</ul>
</div>
<div id="evaluation-6" class="section level4 hasAnchor" number="3.6.2.2">
<h4><span class="header-section-number">3.6.2.2</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-6" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Physical exam with deficiencies in upper extremity pulses/ischemic
changes, but may not be present given collateral flow from axillary
artery to upper extremity</p></li>
<li><p>High index of suspicion with location of injury proximity to course
of axillary artery</p></li>
<li><p>Upper extremity Doppler or CTA if patient is stable for diagnosis</p></li>
</ul>
</div>
<div id="management-7" class="section level4 hasAnchor" number="3.6.2.3">
<h4><span class="header-section-number">3.6.2.3</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-7" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Primary repair or treated with interposition graft</p></li>
<li><p>If hemodynamically stable, can consider covered stent based on
location to thoracic outlet via femoral/brachial approach</p></li>
</ul>
</div>
</div>
<div id="brachial-artery-trauma" class="section level3 hasAnchor" number="3.6.3">
<h3><span class="header-section-number">3.6.3</span> Brachial Artery Trauma<a href="upper-extremity-and-thoracic-outlet.html#brachial-artery-trauma" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What is the mechanism and management of upper extremity brachial
artery trauma?</strong></p>
<div id="etiology-6" class="section level4 hasAnchor" number="3.6.3.1">
<h4><span class="header-section-number">3.6.3.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology-6" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Frequently associated with humerus fractures/elbow dislocation</p></li>
<li><p>Penetrating trauma</p></li>
</ul>
</div>
<div id="evaluation-7" class="section level4 hasAnchor" number="3.6.3.2">
<h4><span class="header-section-number">3.6.3.2</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-7" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Pulse deficit in majority (&gt;75% of cases)</p></li>
<li><p>Upper extremity Doppler of CTA</p></li>
</ul>
</div>
<div id="management-8" class="section level4 hasAnchor" number="3.6.3.3">
<h4><span class="header-section-number">3.6.3.3</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-8" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li>Given course, can be extensively mobilized and repaired in
end-to-end fashion in 50% of cases. Otherwise, treatment with an
interposition graft</li>
</ul>
</div>
</div>
<div id="radialulnar-artery-trauma" class="section level3 hasAnchor" number="3.6.4">
<h3><span class="header-section-number">3.6.4</span> Radial/ulnar artery trauma<a href="upper-extremity-and-thoracic-outlet.html#radialulnar-artery-trauma" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What is the mechanism and management of upper extremity radial/ulnar
artery trauma?</strong></p>
<div id="etiology-7" class="section level4 hasAnchor" number="3.6.4.1">
<h4><span class="header-section-number">3.6.4.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology-7" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li>Associated with significant soft tissue pattern</li>
</ul>
</div>
<div id="evaluation-8" class="section level4 hasAnchor" number="3.6.4.2">
<h4><span class="header-section-number">3.6.4.2</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-8" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Pulse deficit in &gt;80% of patients</p></li>
<li><p>Doppler based Allen test-confirm radial/ulnar contribution to palmar
arch</p></li>
</ul>
</div>
<div id="management-9" class="section level4 hasAnchor" number="3.6.4.3">
<h4><span class="header-section-number">3.6.4.3</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-9" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>If Allen test reveals a patent palmar arch, the injured artery can
be ligated</p></li>
<li><p>If palmar arch is not patent in the absence of contribution of the
injured artery, it should be repaired</p></li>
<li><p>If both are damaged, preference to ulnar artery as dominant
contribution to hand</p></li>
<li><p>Generally, repair can be done in an end to end fashion given
mobility of the vessel</p></li>
</ul>
</div>
</div>
</div>
<div id="compression-syndromes" class="section level2 hasAnchor" number="3.7">
<h2><span class="header-section-number">3.7</span> Compression Syndromes<a href="upper-extremity-and-thoracic-outlet.html#compression-syndromes" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><strong>The main syndromes are quadrilateral space syndrome and humeral
compression of the axillary artery. What important information here do
our listeners need to know?</strong></p>
<div id="quadrilateral-space-syndrome" class="section level3 hasAnchor" number="3.7.1">
<h3><span class="header-section-number">3.7.1</span> Quadrilateral space syndrome<a href="upper-extremity-and-thoracic-outlet.html#quadrilateral-space-syndrome" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Anatomy</p>
<ul>
<li><p>Bordered by teres minor superiorly, humeral shaft laterally, and
teres major inferiorly, and long head of triceps muscle medially</p></li>
<li><p>Posterior humeral circumflex artery and axillary nerve in space</p></li>
</ul>
<p>Etiology</p>
<ul>
<li><p>Compression of posterior humeral circumflex occurs with
abduction/external rotation</p></li>
<li><p>Typically seen with chronic overhand motion athletes
(pitchers/volleyball players)</p></li>
<li><p>Vascular-repetitive mechanical trauma to posterior circumflex
humeral artery</p></li>
<li><p>Neurogenic-fixed structural impaction of quadrilateral space by
fibrous bands or space-occupying lesions</p></li>
</ul>
<p>Presentation</p>
<ul>
<li>Muscle atrophy, paresthesias, poorly localized shoulder pain and
pain in quadrilateral space</li>
</ul>
<p>Management</p>
<ul>
<li><p>Medical: Oral anti-inflammatory medications, PT, limitation of
activities</p></li>
<li><p>Surgery: decompression with neurolysis/excision of fibrous bands or
other space occupying lesions</p></li>
</ul>
</div>
<div id="humeral-head-compression-of-axillary-artery" class="section level3 hasAnchor" number="3.7.2">
<h3><span class="header-section-number">3.7.2</span> Humeral head compression of axillary artery<a href="upper-extremity-and-thoracic-outlet.html#humeral-head-compression-of-axillary-artery" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Anatomy</p>
<ul>
<li>3rd portion of axillary artery compressed by head of humerus</li>
</ul>
<p>Etiology</p>
<ul>
<li>Arm is abducted and externally rotated with downward compression of
humeral head to axillary artery</li>
</ul>
<p>Presentation</p>
<ul>
<li>Arm fatigue, loss of pitch velocity, finger numbness, Raynaud,
cutaneous embolization</li>
</ul>
<p>Evaluation</p>
<ul>
<li><p>Provocative maneuvers with impedance of flow through axillary artery
on ultrasonography</p></li>
<li><p>Arteriography with rest and provocative position</p></li>
</ul>
<p>TManagement</p>
<ul>
<li><p>Supportive with avoidance of throwing motion</p></li>
<li><p>Surgical-saphenous vein patch for no improvement or structural
injury may require resection with saphenous vein bypass anatomically
or extra-anatomic tunneling above pec minor</p></li>
</ul>
</div>
</div>
<div id="thoracic-outlet-syndrome" class="section level2 hasAnchor" number="3.8">
<h2><span class="header-section-number">3.8</span> Thoracic Outlet Syndrome<a href="upper-extremity-and-thoracic-outlet.html#thoracic-outlet-syndrome" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><strong>27 Nov 2019:</strong> <em>Nedal Katib, Prince of Wales, Sydney Australia</em></p>
<audio controls> <source src='https://traffic.libsyn.com/audiblebleeding/VSITE_TOS_02auph.mp3' type='audio/mpeg'> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio>
<p>Thoracic Outlet Syndrome = A constellation of signs and symptoms
relating to the compression of the neurovascular structures that occurs
as these structures travel between the thoracic aperture and the upper
limb.</p>
<p>Types: Neurogenic, Venous and Arterial</p>
<ul>
<li><p>vTOS – 2-3%</p></li>
<li><p>aTOS – 1%</p></li>
<li><p>nTOS – &gt;95%<span class="citation"><sup>[<a href="#ref-humphries124ThoracicOutlet2019" role="doc-biblioref">157</a>]</sup></span></p></li>
</ul>
<div id="anatomy-1" class="section level3 hasAnchor" number="3.8.1">
<h3><span class="header-section-number">3.8.1</span> Anatomy<a href="upper-extremity-and-thoracic-outlet.html#anatomy-1" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Understanding the anatomy of what is collectively referred to as the
thoracic outlet is the best way to thoroughly appreciate this topic.</p>
<p>Anatomy from anterior to posterior</p>
<ul>
<li><p>Subclavian vein</p></li>
<li><p>Phrenic nerve</p></li>
<li><p>Anterior scalene muscle attachment to the first rib</p></li>
<li><p>The subclavian artery</p></li>
<li><p>The brachial plexus</p></li>
<li><p>The middle scalene muscle.</p></li>
</ul>
<p>Three spaces where the neurovascular structures are at risk of
compression:</p>
<ol style="list-style-type: decimal">
<li><p>Interscalene Triangle</p></li>
<li><p>Costoclavicular Passage<span class="citation"><sup>[<a href="#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">87</a>]</sup></span></p></li>
<li><p>Subcoracoid Space<span class="citation"><sup>[<a href="#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">87</a>]</sup></span></p></li>
</ol>
<p><strong>Interscalene Triangle:</strong></p>
<p>Appreciating the attachments of the Anterior and Middle Scalene Muscles
on the first rib becomes important in the diagnosis of the various types
and also the ultimate surgical management of the compression.</p>
<p><strong>Anterior Scalene:</strong></p>
<p>Attachments: Anterior Tubercles of the four ‘typical’ cervical vertebrae
(3-6) AND the scalene tubercle on the upper surface of the first rib.</p>
<ul>
<li>Phrenic nerve runs along anterior scalene muscle and injury can
cause ipsilateral diaphragm paralysis.</li>
</ul>
<p><strong>Middle Scalene:</strong></p>
<p>Attachments: The posterior tubercles and intertubercular lamellae of all
the cervical vertebrae AND the Quadrangular area between the neck and
subclavian groove of the first rib.<span class="citation"><sup>[<a href="#ref-mcminnLastAnatomyRegional2019" role="doc-biblioref">158</a>]</sup></span></p>
<ul>
<li>Long thoracic nerve runs along middle scalene muscle and injury can
cause winged scapula.</li>
</ul>
<p><strong>The First Rib:</strong></p>
<ul>
<li><p>The broadest and flattest of the ribs and is an ‘Atypical Rib’.</p></li>
<li><p>The upper surface of the first rib has the scalene and quadrangular
tubercles for attachments of the anterior and middle scalene muscles
respectively. There are also three grooves for the Subclavian Vein,
artery and the Lower Trunk of the Brachial Plexus.</p></li>
<li><p>The Inferior Surface is smooth and inferior and medially has an
attachment for the suprapleural membrane, Sibson’s fascia AKA
scalenus minimus, which is tethered to the C7 vertebrae.</p></li>
<li><p>This is the passage of the subclavian vein largely as it emerges
through the tight space created by the clavicle, the subclavius
muscle and the costoclavicular ligament and also more posteriorly
this can also compress the artery and nerves as the space can also
be narrow in relation with the scapula and subscapularis.<span class="citation"><sup>[<a href="#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">87</a>]</sup></span></p></li>
</ul>
<p><strong>Subclavius Muscle:</strong></p>
<ul>
<li><p>Attached to the costochondral junction of the first rib and is
inserted into the subclavian groove on the inferior surface of the
clavicle.<span class="citation"><sup>[<a href="#ref-mcminnLastAnatomyRegional2019" role="doc-biblioref">158</a>]</sup></span></p></li>
<li><p>This space is best appreciated by intimate knowledge of three
things:</p>
<ul>
<li><p>The Coracoid Process and its attachments</p></li>
<li><p>The Pectoralis Minor Muscle</p></li>
<li><p>The Clavipectoral Fascia</p></li>
</ul></li>
</ul>
<p><strong>The Coracoid Process:</strong></p>
<ul>
<li><p>Arising from the Scapula as a ‘process’, this broad-based bony
landmark offers attachment to muscles and ligaments.</p></li>
<li><p>The relevant attachments being the pectoralis minor muscle occupying
the medial border for about 2cm behind its tip. The tip itself
having a medial and lateral facet for the short head of biceps and
the coracobrachialis muscles respectively.</p></li>
</ul>
<p><strong>Pectoralis Minor Muscle:</strong></p>
<p>Attached to the bone of the third, fourth and fifth ribs AND the medial
border of the coracoid process.</p>
<p><strong>Clavipectoral Fascia:</strong></p>
<p>A sheet of fascial membrane that fills the space between the clavicle
and pectoralis minor splitting and encompassing the subclavius muscle.
Its superior portion is what can be thickened and become a tight band
referred to as the costocoracoid ligament.</p>
<p><strong>Phrenic Nerve Anomaly:</strong></p>
<p>The Phrenic Nerve normally runs anterior to the Subclavian Vein. A rare
anomaly is the nerve compressing the vein anteriorly and in very rare
circumstances due to the timing of development can run through the vein
itself.</p>
<p>Anomalous anatomy can also cause TOS especially when patients have a
Cervical Rib and anomalous first ribs or a congenital band attaching to
the first rib.</p>
<ul>
<li><p>Incidence of anomalous first ribs and cervical ribs is 0.76% and
0.75% respectively.</p></li>
<li><p>Incidence of bands are as high as 63% in the general population.<span class="citation"><sup>[<a href="#ref-humphries124ThoracicOutlet2019" role="doc-biblioref">157</a>]</sup></span></p></li>
</ul>
<p>nTOS</p>
<ul>
<li><p>Scalene Triangle compression – most common cause of brachial plexus
and neurogenic TOS</p></li>
<li><p>Cervical Rib and Anomalous First Rib</p></li>
</ul>
<p>aTOS</p>
<ul>
<li><p>Cervical Rib and Anomalous First Rib</p></li>
<li><p>Scalene Triangle compression</p></li>
</ul>
<p>vTOS</p>
<ul>
<li><p>Costoclavicular Passage</p></li>
<li><p>Subcoracoid Space</p></li>
</ul>
</div>
<div id="presentation-5" class="section level3 hasAnchor" number="3.8.2">
<h3><span class="header-section-number">3.8.2</span> Presentation<a href="upper-extremity-and-thoracic-outlet.html#presentation-5" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<ul>
<li><p>Identify symptoms and thoroughly interrogate timing</p></li>
<li><p>Exclude history of trauma</p></li>
<li><p>Associated symptoms like headache, visual disturbance, neurology in
the upper limb</p></li>
<li><p>Exclude Carpal Tunnel and Antecubital Tunnel Syndromes if symptoms
are isolated to the arm or forearm or hand</p></li>
<li><p>Patients with vTOS may present acutely and have acute or sub acute
Upper Limb DVT</p></li>
<li><p>Patients with aTOS need to be investigated and assessed urgently
given risk of ischemia.</p></li>
</ul>
</div>
<div id="evaluation-9" class="section level3 hasAnchor" number="3.8.3">
<h3><span class="header-section-number">3.8.3</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-9" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="clinical-examination" class="section level4 hasAnchor" number="3.8.3.1">
<h4><span class="header-section-number">3.8.3.1</span> Clinical Examination<a href="upper-extremity-and-thoracic-outlet.html#clinical-examination" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>Provocative maneuvers are largely used for nTOS. While these are
described and mentioned in most texts their utility largely is beyond
the scope of a vascular surgeon’s assessment and diagnosis of nTOS.</p>
<p><strong>Adson Test</strong></p>
<ul>
<li><p>Extended abducted and externally rotated arm – palpate radial pulse</p></li>
<li><p>Rotate and laterally flex the neck to the ipsilateral side while
inhaling deeply.</p></li>
<li><p>A positive test results in reduction or complete obliteration of
radial pulse</p></li>
</ul>
<p><strong>Roos Test / EAST test</strong></p>
<ul>
<li><p>Patient seated and both arms abducted 90 degrees and externally
rotated and elbows flexed at 90 degrees.</p></li>
<li><p>Open and close hands for 3 minutes or until pain or paraesthesia
sets in.</p></li>
</ul>
<p><strong>Elveys Test</strong></p>
<ul>
<li><p>Abduct both arms to 90 degrees with elbows extended and dorsiflex
both wrists.</p></li>
<li><p>If pain is elicited as wrists dorsiflexed then test is positive.</p></li>
<li><p>A further manoeuvre is then performed, laterally flex the head on
each side, if pain is elicited on the contralateral side to which
the head is flexed then test is positive.<span class="citation"><sup>[<a href="#ref-humphries124ThoracicOutlet2019" role="doc-biblioref">157</a>]</sup></span></p></li>
</ul>
</div>
<div id="non-invasive-imaging-or-vascular-lab-studies" class="section level4 hasAnchor" number="3.8.3.2">
<h4><span class="header-section-number">3.8.3.2</span> Non-invasive imaging or vascular lab studies<a href="upper-extremity-and-thoracic-outlet.html#non-invasive-imaging-or-vascular-lab-studies" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>DBI</p></li>
<li><p>Arterial Duplex</p></li>
<li><p>Venous Duplex</p></li>
<li><p>CT – CTV commonly performed in acute upper limb DVT and suspicion
of vTOS</p></li>
<li><p>CTA for the evaluation of aTOS and excluding other causes of
embolisation</p></li>
<li><p>MRI – for further evaluation of the anatomy and related
neurovascular compression</p></li>
<li><p>Electromyography and Nerve Conduction Studies for nTOS</p></li>
</ul>
</div>
</div>
<div id="management-10" class="section level3 hasAnchor" number="3.8.4">
<h3><span class="header-section-number">3.8.4</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-10" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>After the appropriate evaluation, if decompression of thoracic outlet is
deemed appropriate, there are multiple approaches to the first rib
resections.</p>
<table style="width:94%;">
<colgroup>
<col width="16%" />
<col width="38%" />
<col width="38%" />
</colgroup>
<thead>
<tr class="header">
<th></th>
<th>Advantages</th>
<th>Disadvantages</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Transa
xillary</strong></td>
<td>Cosmetically more
appealing as it has a
limited hidden scar</td>
<td><p>Difficult to visualize
the anatomy, dependent
on good assistance</p>
<p>Risk of injury to T1
nerve root, phrenic
nerve, long thoracic,
brachial plexus ,
subclavian vein and
arterial with limited
exposure to repair</p>
<p>Not able to approach
cervical ribs, scalene
triangle or patch vein.</p></td>
</tr>
<tr class="even">
<td><ul>
<li>*Supracla
vicular**</li>
</ul></td>
<td><p>Good for scalene triangle
access and debulking and
cervical rib resection</p>
<p>Required for aTOS if
arterial reconstruction
necessary</p></td>
<td><p>Unable to decompress
venous compression or
visualize vein
adequately</p>
<p>Cosmetically less
appealing</p></td>
</tr>
<tr class="odd">
<td><ul>
<li>*Infracla
vicular**</li>
</ul></td>
<td><p>Good access for venous
decompression</p>
<p>Allows for excision of
subclavius muscle and
costoclavicular ligament</p></td>
<td><p>Unable to expose
subclavian artery or
decompress brachial
plexus.</p>
<p>Difficult to access
most posterior aspect
of rib</p>
<p>Cosmetically less
appealing</p></td>
</tr>
<tr class="even">
<td><strong>Paracla
vicular</strong></td>
<td>Useful if mixed etiology
TOS to adequately
decompression all
neurovascular structures</td>
<td>Requires two incisions
one above and below the
clavicle</td>
</tr>
</tbody>
</table>
<p><span class="citation"><sup>[<a href="#ref-siracuseInfraclavicularFirstRib2015" role="doc-biblioref">159</a>]</sup></span></p>
<div id="post-operative-complications" class="section level4 hasAnchor" number="3.8.4.1">
<h4><span class="header-section-number">3.8.4.1</span> Post operative complications<a href="upper-extremity-and-thoracic-outlet.html#post-operative-complications" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Post operative patients with hemodynamic instability and ipsilateral
effusion on xray should go back to OR for exploration and hemorrhage
control.<span class="citation"><sup>[<a href="#ref-rinehardtCurrentPracticeThoracic2017" role="doc-biblioref">160</a>]</sup></span></p></li>
<li><p>Chyle leak often managed with adequate drainage and medium chain
fatty acid diet. Persistent leak should undergo wound exploration
and ligation of thoracic duct (most often encountered on the left)
or VATS thoracic duct ligation.<span class="citation"><sup>[<a href="#ref-delaney2017" role="doc-biblioref">161</a>]</sup></span> IR embolization has
also been shown to be effective.<span class="citation"><sup>[<a href="#ref-cope1999" role="doc-biblioref">162</a>]</sup></span></p></li>
</ul>
</div>
</div>
<div id="vtos" class="section level3 hasAnchor" number="3.8.5">
<h3><span class="header-section-number">3.8.5</span> vTOS<a href="upper-extremity-and-thoracic-outlet.html#vtos" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="demographics" class="section level4 hasAnchor" number="3.8.5.1">
<h4><span class="header-section-number">3.8.5.1</span> Demographics<a href="upper-extremity-and-thoracic-outlet.html#demographics" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Incidence: 2/100,000 persons</p></li>
<li><p>Age: 18 years to 30 years<span class="citation"><sup>[<a href="#ref-illigComprehensiveReviewPagetSchroetter2010" role="doc-biblioref">163</a>]</sup></span></p></li>
<li><p>M&gt;F</p></li>
<li><p><strong>Paget Schroetter Syndrome</strong></p>
<ul>
<li><p>First defined by Hughes in 1949 in reference to Sir James Paget
who in a hundred years earlier defined acute arm swelling and
pain as possibly related to vasospasm and then von Schroetter
who in 1884 attributed to the presentation to subclavian and
axillary vein thrombosis.<span class="citation"><sup>[<a href="#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">164</a>]</sup></span></p></li>
<li><p>Now vTOS and Paget Schroetter Syndrome are used synonymously.</p></li>
<li><p>Paget Schroetter Syndrome accounts for 10-20% of all upper
extremity deep vein thrombosis.<span class="citation"><sup>[<a href="#ref-sekharYearbookVascularEndovascular2018" role="doc-biblioref">165</a>]</sup></span></p></li>
</ul></li>
</ul>
</div>
<div id="presentation-6" class="section level4 hasAnchor" number="3.8.5.2">
<h4><span class="header-section-number">3.8.5.2</span> Presentation<a href="upper-extremity-and-thoracic-outlet.html#presentation-6" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Upper Limb edema, pain and cyanosis. Edema affects the shoulder, arm
and hand and characteristically non pitting.</p></li>
<li><p>Collateral vein dilatation over the shoulder, neck and anterior
chest wall to accommodate for the increased venous hypertension.<span class="citation"><sup>[<a href="#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">164</a>]</sup></span></p></li>
<li><p>Pain on exertion of the upper limb described as stabbing, aching or
tightness.</p></li>
<li><p>The reported incidence of PE following Upper Limb DVT is &lt;12%.<span class="citation"><sup>[<a href="#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">164</a>]</sup></span></p></li>
</ul>
</div>
<div id="evaluation-10" class="section level4 hasAnchor" number="3.8.5.3">
<h4><span class="header-section-number">3.8.5.3</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-10" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>A differential diagnosis for Upper Limb DVT</p>
<ul>
<li><p>vTOS</p></li>
<li><p>Congenital Phrenic Nerve anomaly</p></li>
<li><p>History of Fracture, Clavicular Fracture and malunion</p></li>
<li><p>Repetitive arm provocative manoeuvres, check occupation and
history of body-building</p>
<ul>
<li>Pectoralis Minor Hypertrophy.</li>
</ul></li>
</ul></li>
<li><p>Exclude Pulmonary Embolism</p></li>
<li><p>Exclude Venous Gangrene and Phlegmasia of the upper limb</p></li>
</ul>
</div>
<div id="management-11" class="section level4 hasAnchor" number="3.8.5.4">
<h4><span class="header-section-number">3.8.5.4</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-11" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>Limited evidence due to lack of RCT’s. Majority of evidence based on
retrospective studies.</p>
<ul>
<li><p>Prevent immediate risk</p></li>
<li><p>Return patient to unrestricted use of the affected extremity</p></li>
<li><p>Prevent recurrence of thrombosis without the need of long-term
anticoagulation</p></li>
<li><p>Prevent long term Post Phlebitic Limb Syndrome</p></li>
</ul>
<div id="medical-management" class="section level5 hasAnchor" number="3.8.5.4.1">
<h5><span class="header-section-number">3.8.5.4.1</span> Medical Management<a href="upper-extremity-and-thoracic-outlet.html#medical-management" class="anchor-section" aria-label="Anchor link to header"></a></h5>
<ul>
<li><p>As per ACCP Guidelines: Initial management is anticoagulation
regardless of etiology.<span class="citation"><sup>[<a href="#ref-kearonAntithromboticTherapyVTE2016" role="doc-biblioref">166</a>]</sup></span></p>
<ul>
<li><p>The limitations of anticoagulation alone are that the slow
recanalization of the thrombus may lead to eventual valvular
damage and intravenous scarring.<span class="citation"><sup>[<a href="#ref-sekharYearbookVascularEndovascular2018" role="doc-biblioref">165</a>]</sup></span></p></li>
<li><p>Thrombolysis has been considered superior to anticoagulation
alone in minimizing valvular damage due to residual clot.<span class="citation"><sup>[<a href="#ref-urschelSurgeryRemainsMost2008" role="doc-biblioref">167</a>]</sup></span></p></li>
<li><p>Systemic Lysis – non favored due to risk of intracranial
hemorrhage.<span class="citation"><sup>[<a href="#ref-grunwaldCatheterDirectedThrombolysisTreatment2004" role="doc-biblioref">168</a>]</sup></span></p></li>
<li><p>Catheter Directed Lysis (CDT) – carries a lower risk of
intracranial hemorrhage.</p></li>
<li><p>Patient should be maintained in a compression sleeve until
definitive decompression can be performed.</p></li>
</ul></li>
<li><p>Optimal timing of CDT</p>
<ul>
<li>Within 14 days of onset of thrombosis. Excellent results have
been reported following CDT if initiated before 14 days.<span class="citation"><sup>[<a href="#ref-wilsonFibrinolyticTherapyIdiopathic1990" role="doc-biblioref">169</a>]</sup></span></li>
</ul></li>
</ul>
</div>
<div id="surgery" class="section level5 hasAnchor" number="3.8.5.4.2">
<h5><span class="header-section-number">3.8.5.4.2</span> Surgery<a href="upper-extremity-and-thoracic-outlet.html#surgery" class="anchor-section" aria-label="Anchor link to header"></a></h5>
<ul>
<li><p>After initial management patients are generally divided into two
groups, unsuccessful or successful thrombolysis.</p></li>
<li><p>Persistent stenosis or signs of extrinsic compression, on
venography, has generally been perceived as a significant risk of
recurrent thrombosis.</p></li>
<li><p>Surgery for vTOS remains to be mainly Rib Resection and
decompression of the subclavian vein with or without venolysis and
patch plasty either surgical or endovenous.</p></li>
<li><p>Surgical treatment of severe resistant subclavian vein stenosis in
the setting of vTOS is rib resection by paraclavicular approach and
vein patch plasty.<span class="citation"><sup>[<a href="#ref-melbyComprehensiveSurgicalManagement2008" role="doc-biblioref">170</a>]</sup></span></p></li>
<li><p>Venous occlusion in vTOS may be treated with jugular turn down or
venous bypass to IJ of SVC if patients remain symptomatic.<span class="citation"><sup>[<a href="#ref-vemuriDiagnosisTreatmentEffortinduced2016" role="doc-biblioref">171</a>]</sup></span></p></li>
</ul>
</div>
</div>
<div id="summary" class="section level4 hasAnchor" number="3.8.5.5">
<h4><span class="header-section-number">3.8.5.5</span> Summary<a href="upper-extremity-and-thoracic-outlet.html#summary" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<div id="controversy" class="section level5 hasAnchor" number="3.8.5.5.1">
<h5><span class="header-section-number">3.8.5.5.1</span> Controversy<a href="upper-extremity-and-thoracic-outlet.html#controversy" class="anchor-section" aria-label="Anchor link to header"></a></h5>
<ul>
<li><p>There is a lack of consensus around the necessity of surgical rib
resection, the timing and the requirement for vein patch plasty.</p></li>
<li><p>Options post recanalization:</p>
<ul>
<li><p>Deferring surgical decompression for 1-3 months after
thrombolysis to allow for healing of the venous endothelium and
resolution of the acute inflammatory process.<span class="citation"><sup>[<a href="#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">164</a>]</sup></span></p></li>
<li><p>Decompression during the same admission, as the thrombolysis,
with the main benefit being to reduce the risk of re-occlusion.<span class="citation"><sup>[<a href="#ref-humphries123ThoracicOutlet2019" role="doc-biblioref">164</a>,<a href="#ref-molinaPagetSchroetterSyndromeTreated2007" role="doc-biblioref">172</a>]</sup></span></p></li>
<li><p>Post decompression venography and treatment 2 weeks post rib
resection may help to prevent recurrence and long term vein
patency.<span class="citation"><sup>[<a href="#ref-changRoutineVenographyFollowing2012" role="doc-biblioref">173</a>]</sup></span></p></li>
</ul></li>
</ul>
</div>
<div id="landmark-papers" class="section level5 hasAnchor" number="3.8.5.5.2">
<h5><span class="header-section-number">3.8.5.5.2</span> Landmark papers<a href="upper-extremity-and-thoracic-outlet.html#landmark-papers" class="anchor-section" aria-label="Anchor link to header"></a></h5>
<ol style="list-style-type: decimal">
<li><p>Lugo J et al – Acute Paget Schroetter syndrome: does the first rib
routinely need to be removed after thrombolysis? Annals of Vascular
Surgery 2015<span class="citation"><sup>[<a href="#ref-lugoAcutePagetSchroetter2015" role="doc-biblioref">174</a>]</sup></span></p>
<ol style="list-style-type: decimal">
<li><p>Systematic literature review analysis. Patients divided into
three groups</p>
<ol style="list-style-type: decimal">
<li><p>First Rib resection (FRR) – n=448</p></li>
<li><p>First Rib resection and endovenous venoplasty (FRR and
PLASTY) n=68</p></li>
<li><p>No further intervention after Thrombolysis n=168</p></li>
</ol></li>
<li><p>Symptom relief after initial follow up more likely in FRR (95%)
and FRR and PLASTY (93%) compared to no rib removed (54%) –
p&lt;0.0001</p></li>
<li><p>Results showed superior patency with FRR and PLASTY and FRR
compared to anticoagulation alone.</p></li>
<li><p>Conclusion was that patients are more likely to experience
greater long-term results with FRR compared to no FRR.</p></li>
</ol></li>
<li><p>Sajid MS et al – Upper limb vein thrombosis: a literature review to
streamline the protocol for management. Acta Haematology 2007<span class="citation"><sup>[<a href="#ref-sajidUpperLimbDeep2007" role="doc-biblioref">175</a>]</sup></span></p>
<ul>
<li>Comprehensive review identifying the key papers on this topic
and allows for a clear view of the best management strategy.</li>
</ul></li>
<li><p>Vemuri, C., Salehi, P., Benarroch-Gampel, J., McLaughlin, L. N., &amp;
Thompson, R. W. (2016). Diagnosis and treatment of effort-induced
thrombosis of the axillary subclavian vein due to venous thoracic
outlet syndrome. <em>Journal of Vascular Surgery: Venous and Lymphatic
Disorders</em>, <em>4</em>(4), 485–500.<span class="citation"><sup>[<a href="#ref-vemuriDiagnosisTreatmentEffortinduced2016" role="doc-biblioref">171</a>]</sup></span></p>
<ul>
<li>Comprehensive summary of management strategy for effort induced
thrombosis.</li>
</ul></li>
</ol>
</div>
</div>
</div>
<div id="atos" class="section level3 hasAnchor" number="3.8.6">
<h3><span class="header-section-number">3.8.6</span> aTOS<a href="upper-extremity-and-thoracic-outlet.html#atos" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="presentation-7" class="section level4 hasAnchor" number="3.8.6.1">
<h4><span class="header-section-number">3.8.6.1</span> Presentation<a href="upper-extremity-and-thoracic-outlet.html#presentation-7" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Most common: Hand ischemia due to arterial compression or
microembolization with subclavian artery aneurysm and pulsatile
supraclavicular mass<span class="citation"><sup>[<a href="#ref-boll122ThoracicOutlet2019" role="doc-biblioref">176</a>]</sup></span></p></li>
<li><p>Less common: Exertional pain, unilateral Raynaud’s Phenomena,
retrograde embolisation and neurological symptoms</p></li>
<li><p>Differential Diagnosis</p>
<ul>
<li><p>Trauma</p></li>
<li><p>Primary and Secondary Raynaud’s Phenomena</p></li>
<li><p>Small Vessel Vasculitis</p></li>
<li><p>Connective Tissue Disorders</p></li>
<li><p>Thromboangiitis Obliterans</p></li>
<li><p>Arterial Embolisation – Aortic or Central Source</p></li>
<li><p>Radiation Arteritis</p></li>
<li><p>Atherosclerotic / Dissection causes</p></li>
</ul></li>
<li><p>The different anatomical abnormalities causing aTOS<span class="citation"><sup>[<a href="#ref-boll122ThoracicOutlet2019" role="doc-biblioref">176</a>]</sup></span></p>
<ul>
<li><p>Cervical Rib (60%)</p></li>
<li><p>Anomalous First Rib (18%)</p></li>
<li><p>Fibrocartilaginous band (15%)</p></li>
<li><p>Clavicular Fracture (6%)</p></li>
<li><p>Enlarged C7 transverse process (1%)</p></li>
</ul></li>
</ul>
</div>
<div id="evaluation-11" class="section level4 hasAnchor" number="3.8.6.2">
<h4><span class="header-section-number">3.8.6.2</span> Evaluation<a href="upper-extremity-and-thoracic-outlet.html#evaluation-11" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>Clinical Examination</p>
<ul>
<li><p>Audible Bruit / Palpable thrill over the supraclavicular fossa</p></li>
<li><p>Pulsatile mass</p></li>
<li><p>Distal ischemic lesions in the distal hand – Splinter hemorrhages</p></li>
<li><p>Positive Adson Test</p></li>
</ul>
<p>Most useful studies are pulse volume recordings (PVR) and duplex to
identify aneurysm or sites of embolization. Stress test is not reliable
for diagnosis.<span class="citation"><sup>[<a href="#ref-vemuriClinicalPresentationManagement2017" role="doc-biblioref">177</a>,<a href="#ref-criadoSpectrumArterialCompression2010" role="doc-biblioref">178</a>]</sup></span></p>
</div>
<div id="management-12" class="section level4 hasAnchor" number="3.8.6.3">
<h4><span class="header-section-number">3.8.6.3</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-12" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Symptomatic patients are generally indicated for treatment. Unlike
asymptomatic patients in whom it may be appropriate to manage
conservatively.<span class="citation"><sup>[<a href="#ref-boll122ThoracicOutlet2019" role="doc-biblioref">176</a>]</sup></span></p>
<ul>
<li><p>Scher Staging of aTOS</p>
<ul>
<li><p>Stage 0: Asymptomatic</p></li>
<li><p>Stage 1: Stenosis of Subclavian Artery with minor post
stenotic dilatation with no intimal disruption</p></li>
<li><p>Stage 2: Subclavian artery aneurysm with intimal damage and
mural thrombus</p></li>
<li><p>Stage 3: Distal embolisation from subclavian artery disease</p></li>
</ul></li>
</ul></li>
<li><p>Supraclavicular rib resection is the most suitable for adequate
arterial reconstruction. Transaxillary has been argued to offer more
complete rib resection however arterial repair is not possible in
this approach.</p></li>
<li><p>Subclavian artery repair is necessary in Scher Stages 2 and 3 and in
some cases 1. Arterial repair with conduit either GSV, Femoral Vein
or prosthetic have been described. Ringed PTFE offers good patency
and resistance to kinking in this functional anatomical location.</p></li>
</ul>
</div>
</div>
<div id="ntos" class="section level3 hasAnchor" number="3.8.7">
<h3><span class="header-section-number">3.8.7</span> nTOS<a href="upper-extremity-and-thoracic-outlet.html#ntos" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="demographics-1" class="section level4 hasAnchor" number="3.8.7.1">
<h4><span class="header-section-number">3.8.7.1</span> Demographics<a href="upper-extremity-and-thoracic-outlet.html#demographics-1" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>Neurogenic TOS is largely a clinical diagnosis with symptoms and signs
pertaining to nerve compression most commonly the lower trunk of the
brachial plexus.</p>
<ul>
<li><p>F&gt;M – 70% Female</p></li>
<li><p>Ages 20-40</p></li>
<li><p>Occupational Exposure</p></li>
<li><p>Trauma history - often associated with recent history of neck
trauma.</p></li>
</ul>
</div>
<div id="presentation-8" class="section level4 hasAnchor" number="3.8.7.2">
<h4><span class="header-section-number">3.8.7.2</span> Presentation<a href="upper-extremity-and-thoracic-outlet.html#presentation-8" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<ul>
<li><p>Symptoms<span class="citation"><sup>[<a href="#ref-sadeghi-azandaryaniThoracicOutletSyndrome2009" role="doc-biblioref">179</a>,<a href="#ref-sandersDiagnosisThoracicOutlet2007" role="doc-biblioref">180</a>]</sup></span></p>
<ul>
<li><p>Paraesthesia (98%)</p></li>
<li><p>Trapezius pain (92%)</p></li>
<li><p>Neck, shoulder or arm pain (88%) - usually involves nerve roots
so isolated hand symptoms is rare.</p></li>
<li><p>Supraclavicular pain with or without occipital headache (76%)</p></li>
<li><p>Chest pain (72%)</p></li>
<li><p>Weakness</p></li>
<li><p>Swelling</p></li>
</ul></li>
<li><p>Positional Effects</p>
<ul>
<li><p>Reproducible exacerbation of symptoms</p></li>
<li><p>Lying supine with arms overhead</p></li>
<li><p>Overhead activities -occupational or recreational</p></li>
</ul></li>
<li><p>Weakness and Muscle Atrophy</p>
<ul>
<li><p>Hypothenar atrophy</p></li>
<li><p>Drop-off in athletic performance</p></li>
<li><p>Inability to carry out activities of daily living</p></li>
</ul></li>
</ul>
</div>
<div id="management-13" class="section level4 hasAnchor" number="3.8.7.3">
<h4><span class="header-section-number">3.8.7.3</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-13" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>As the patient has already seen multiple specialists and
physiotherapists, the role of the vascular surgeon with nTOS is often
limited but should focus on:</p>
<ul>
<li><p>Exclude other causes</p></li>
<li><p>Confirm diagnosis – Neurophysiologic Tests (EMG and NCS)</p></li>
<li><p>Seek alternate opinion</p></li>
<li><p>Trial of Physiotherapy and non-operative management - patients
should be evaluated and undergo a 6 week course of physical therapy.
This physical therapy focuses on scalene and pectoralis stretching
improving mobility of the shoulder and strengthening the arm. Many
improve with physical therapy.<span class="citation"><sup>[<a href="#ref-baldermanPhysicalTherapyManagement2019" role="doc-biblioref">181</a>]</sup></span></p></li>
<li><p>Anterior scalene lidocaine block may provide temporary symptom
relief (~7 days) and may help identify those patients most likely
to benefit from surgical decompression.<span class="citation"><sup>[<a href="#ref-salhanPC214UltrasoundGuidedAnesthetic2016" role="doc-biblioref">182</a>,<a href="#ref-lumImpactAnteriorScalene2012" role="doc-biblioref">183</a>]</sup></span></p></li>
<li><p>Botulinum injection may give an average of 6 weeks of relief.<span class="citation"><sup>[<a href="#ref-salhanPC214UltrasoundGuidedAnesthetic2016" role="doc-biblioref">182</a>]</sup></span></p></li>
<li><p>Be selective in patients who may require surgery</p></li>
</ul>
<p>Surgery with Rib resection often is accomplished with transaxillary or
supraclavicular approach, particularly if scalenectomy or cervical rib
resection is necessary.</p>
</div>
</div>
</div>
<div id="upper-extremity-lymphedema" class="section level2 hasAnchor" number="3.9">
<h2><span class="header-section-number">3.9</span> Upper Extremity Lymphedema<a href="upper-extremity-and-thoracic-outlet.html#upper-extremity-lymphedema" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<div id="etiology-8" class="section level3 hasAnchor" number="3.9.1">
<h3><span class="header-section-number">3.9.1</span> Etiology<a href="upper-extremity-and-thoracic-outlet.html#etiology-8" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Often due to breast cancer therapy and axillary lymph node
dissection.<span class="citation"><sup>[<a href="#ref-morrell2005" role="doc-biblioref">184</a>]</sup></span></p>
</div>
<div id="management-14" class="section level3 hasAnchor" number="3.9.2">
<h3><span class="header-section-number">3.9.2</span> Management<a href="upper-extremity-and-thoracic-outlet.html#management-14" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Initial treatment includes decongestive therapy, such as daily massage
for 2-4 weeks. Once the girth and symptoms stabilize, then can
transition to long term management with compression sleeve.<span class="citation"><sup>[<a href="#ref-mondry2004" role="doc-biblioref">185</a>]</sup></span></p>
<p>Severe cases my require lymph node transfer.<span class="citation"><sup>[<a href="#ref-warren2007" role="doc-biblioref">186</a>]</sup></span></p>
<p>Lymphangiosarcoma in the setting of lymphedema (Stewart-Treves syndrome)
without distant disease is best managed with wide local excision and
adjuvant chemoradiation. Prognosis is poor.<span class="citation"><sup>[<a href="#ref-sharma2012" role="doc-biblioref">187</a>]</sup></span></p>

</div>
</div>
</div>
<h3>References<a href="references.html#references" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="refs" class="references csl-bib-body hanging-indent" line-spacing="2">
<div id="ref-berguer1998" class="csl-entry">
63. Berguer, R., Morasch, M. D., &amp; Kline, R. A. (1998). Transthoracic repair of innominate and common carotid artery disease: Immediate and long-term outcome for 100 consecutive surgical reconstructions. <em>Journal of Vascular Surgery</em>, <em>27</em>(1), 34–41; discussion 42. <a href="https://doi.org/10.1016/s0741-5214(98)70289-7">https://doi.org/10.1016/s0741-5214(98)70289-7</a>
</div>
<div id="ref-illig57UpperExtremity2019" class="csl-entry">
86. Illig, K. A. (2019). 57. <span>Upper Extremity Vascular Exposure</span>. In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em> (p. 12). <span>Elsevier Inc.</span>
</div>
<div id="ref-garygwindAnatomicExposuresVascular2013" class="csl-entry">
87. Gary G Wind, &amp; R. James Valentine. (2013). <em>Anatomic <span>Exposures</span> in <span>Vascular Surgery</span></em> (Second). <span>Lippincott Williams &amp; Wilkins</span>.
</div>
<div id="ref-dumfarth2015" class="csl-entry">
88. Dumfarth, J., Chou, A. S., Ziganshin, B. A., Bhandari, R., Peterss, S., Tranquilli, M., Mojibian, H., Fang, H., Rizzo, J. A., &amp; Elefteriades, J. A. (2015). Atypical aortic arch branching variants: A novel marker for thoracic aortic disease. <em>The Journal of Thoracic and Cardiovascular Surgery</em>, <em>149</em>(6), 1586–1592. <a href="https://doi.org/10.1016/j.jtcvs.2015.02.019">https://doi.org/10.1016/j.jtcvs.2015.02.019</a>
</div>
<div id="ref-layton2006" class="csl-entry">
89. Layton, K. F., Kallmes, D. F., Cloft, H. J., Lindell, E. P., &amp; Cox, V. S. (2006). Bovine aortic arch variant in humans: Clarification of a common misnomer. <em>AJNR: American Journal of Neuroradiology</em>, <em>27</em>(7), 1541–1542. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977516/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977516/</a>
</div>
<div id="ref-shuja117UpperExtremity" class="csl-entry">
90. Shuja, F. (n.d.). <em>117. <span>Upper Extremity Arterial Disease</span>: <span>Epidemiology</span>, <span>Etiology</span>, and <span>Diagnostic Evaluation</span></em> (p. 11).
</div>
<div id="ref-wahlberg2006" class="csl-entry">
91. Wahlberg, E., Goldstone, J., &amp; Olofsson, P. (2006). <em>Emergency vascular surgery: A practical guide</em>. Springer-Verlag. Springer e-books.
</div>
<div id="ref-henke2009" class="csl-entry">
92. Henke, P. K. (2009). Contemporary management of acute limb ischemia: Factors associated with amputation and in-hospital mortality. <em>Seminars in Vascular Surgery</em>, <em>22</em>(1), 34–40. <a href="https://doi.org/10.1053/j.semvascsurg.2009.01.002">https://doi.org/10.1053/j.semvascsurg.2009.01.002</a>
</div>
<div id="ref-tran2011" class="csl-entry">
93. Tran, D. D., &amp; Andersen, C. A. (2011). Axillary sheath hematomas causing neurologic complications following arterial access. <em>Annals of Vascular Surgery</em>, <em>25</em>(5), 697.e5–8. <a href="https://doi.org/10.1016/j.avsg.2010.12.024">https://doi.org/10.1016/j.avsg.2010.12.024</a>
</div>
<div id="ref-gelberman1981" class="csl-entry">
94. Gelberman, R. H., Garfin, S. R., Hergenroeder, P. T., Mubarak, S. J., &amp; Menon, J. (1981). Compartment syndromes of the forearm: Diagnosis and treatment. <em>Clinical Orthopaedics and Related Research</em>, <em>161</em>, 252–261.
</div>
<div id="ref-leversedge2011" class="csl-entry">
96. Leversedge, F. J., Moore, T. J., Peterson, B. C., &amp; Seiler, J. G. (2011). Compartment syndrome of the upper extremity. <em>The Journal of Hand Surgery</em>, <em>36</em>(3), 544–559; quiz 560. <a href="https://doi.org/10.1016/j.jhsa.2010.12.008">https://doi.org/10.1016/j.jhsa.2010.12.008</a>
</div>
<div id="ref-ronel2004" class="csl-entry">
97. Ronel, D. N., Mtui, E., &amp; Nolan, W. B. (2004). Forearm compartment syndrome: Anatomical analysis of surgical approaches to the deep space. <em>Plastic and Reconstructive Surgery</em>, <em>114</em>(3), 697–705. <a href="https://doi.org/10.1097/01.prs.0000130967.42426.23">https://doi.org/10.1097/01.prs.0000130967.42426.23</a>
</div>
<div id="ref-jacklcronenwettVascularDecisionMaking2020" class="csl-entry">
98. Jack L Cronenwett, Alik Farber, &amp; Erica L. Mitchell. (2020). <em>Vascular <span>Decision Making</span>: <span>Medical</span>, <span>Endovascular</span>, <span>Surgical</span></em>. <span>Wolters Kluwer</span>.
</div>
<div id="ref-rodriguez2016" class="csl-entry">
99. Rodriguez, J. D. (2016). Brachiocephalic artery disease progression resulting in complex steal phenomena. <em>Journal of Diagnostic Medical Sonography</em>, <em>32</em>(3), 173–180. <a href="https://doi.org/10.1177/8756479316649950">https://doi.org/10.1177/8756479316649950</a>
</div>
<div id="ref-goldstein2010" class="csl-entry">
100. Goldstein, L. J., Ayers, J. D., Hollenbeck, S., Spector, J. A., &amp; Vouyouka, A. G. (2010). Successful revascularization for delayed presentation of radiation-induced distal upper extremity ischemia. <em>Annals of Vascular Surgery</em>, <em>24</em>(2), 257.e5–8. <a href="https://doi.org/10.1016/j.avsg.2009.07.024">https://doi.org/10.1016/j.avsg.2009.07.024</a>
</div>
<div id="ref-modrall2003" class="csl-entry">
101. Modrall, J. G., &amp; Sadjadi, J. (2003). Early and late presentations of radiation arteritis. <em>Seminars in Vascular Surgery</em>, <em>16</em>(3), 209–214. <a href="https://doi.org/10.1016/s0895-7967(03)00026-7">https://doi.org/10.1016/s0895-7967(03)00026-7</a>
</div>
<div id="ref-chatterjeeAngioplastyAloneAngioplasty2013" class="csl-entry">
102. Chatterjee, S., Nerella, N., Chakravarty, S., &amp; Shani, J. (2013). Angioplasty <span>Alone Versus Angioplasty</span> and <span>Stenting</span> for <span>Subclavian Artery Stenosis</span> and <span class="nocase">Meta-analysis</span>. <em>American Journal of Therapeutics</em>, <em>20</em>(5), 520–523. <a href="https://doi.org/10.1097/MJT.0b013e31822831d8">https://doi.org/10.1097/MJT.0b013e31822831d8</a>
</div>
<div id="ref-mordasini2011" class="csl-entry">
106. Mordasini, P., Gralla, J., Do, D.-D., Schmidli, J., Keserü, B., Arnold, M., Fischer, U., Schroth, G., &amp; Brekenfeld, C. (2011). Percutaneous and open retrograde endovascular stenting of symptomatic high-grade innominate artery stenosis: Technique and follow-up. <em>AJNR: American Journal of Neuroradiology</em>, <em>32</em>(9), 1726–1731. <a href="https://doi.org/10.3174/ajnr.A2598">https://doi.org/10.3174/ajnr.A2598</a>
</div>
<div id="ref-aiello2011" class="csl-entry">
107. Aiello, F., &amp; Morrissey, N. J. (2011). Open and endovascular management of subclavian and innominate arterial pathology. <em>Seminars in Vascular Surgery</em>, <em>24</em>(1), 31–35. <a href="https://doi.org/10.1053/j.semvascsurg.2011.04.001">https://doi.org/10.1053/j.semvascsurg.2011.04.001</a>
</div>
<div id="ref-byrne2007" class="csl-entry">
112. Byrne, J., Darling, R. C., Roddy, S. P., Mehta, M., Paty, P. S. K., Kreienberg, P. B., Chang, B. B., Ozsvath, K. J., Sternbach, Y., &amp; Shah, D. M. (2007). Long term outcome for extra-anatomic arch reconstruction. An analysis of 143 procedures. <em>European Journal of Vascular and Endovascular Surgery</em>, <em>34</em>(4), 444–450. <a href="https://doi.org/10.1016/j.ejvs.2007.05.016">https://doi.org/10.1016/j.ejvs.2007.05.016</a>
</div>
<div id="ref-cinà2002" class="csl-entry">
113. Cinà, C. S., Safar, H. A., Laganà, A., Arena, G., &amp; Clase, C. M. (2002). Subclavian carotid transposition and bypass grafting: Consecutive cohort study and systematic review. <em>Journal of Vascular Surgery</em>, <em>35</em>(3), 422–429. <a href="https://doi.org/10.1067/mva.2002.120035">https://doi.org/10.1067/mva.2002.120035</a>
</div>
<div id="ref-vandervliet1995" class="csl-entry">
114. Vliet, J. A. van der, Palamba, H. W., Scharn, D. M., Roye, S. F. S. van, &amp; Buskens, F. G. M. (1995). Arterial reconstruction for subclavian obstructive disease: A comparison of extrathoracic procedures. <em>European Journal of Vascular and Endovascular Surgery</em>, <em>9</em>(4), 454–458. <a href="https://doi.org/10.1016/S1078-5884(05)80015-2">https://doi.org/10.1016/S1078-5884(05)80015-2</a>
</div>
<div id="ref-aburahma2000" class="csl-entry">
115. AbuRahma, A. F., Robinson, P. A., &amp; Jennings, T. G. (2000). Carotid-subclavian bypass grafting with polytetrafluoroethylene grafts for symptomatic subclavian artery stenosis or occlusion: A 20-year experience. <em>Journal of Vascular Surgery</em>, <em>32</em>(3), 411–419. <a href="https://doi.org/10.1067/mva.2000.108644">https://doi.org/10.1067/mva.2000.108644</a>
</div>
<div id="ref-ziomek1986" class="csl-entry">
117. Ziomek, S., Quiñones-Baldrich, W. J., Busuttil, R. W., Baker, J. D., Machleder, H. I., &amp; Moore, W. S. (1986). The superiority of synthetic arterial grafts over autologous veins in carotid-subclavian bypass. <em>Journal of Vascular Surgery</em>, <em>3</em>(1), 140–145.
</div>
<div id="ref-voigtOutcomesCarotidsubclavianBypass2019" class="csl-entry">
118. Voigt, S. L., Bishawi, M., Ranney, D., Yerokun, B., McCann, R. L., &amp; Hughes, G. C. (2019). Outcomes of carotid-subclavian bypass performed in the setting of thoracic endovascular aortic repair. <em>Journal of Vascular Surgery</em>, <em>69</em>(3), 701–709. <a href="https://doi.org/10.1016/j.jvs.2018.07.022">https://doi.org/10.1016/j.jvs.2018.07.022</a>
</div>
<div id="ref-moraschTechniqueSubclavianCarotid2009d" class="csl-entry">
119. Morasch, M. D. (2009). Technique for subclavian to carotid transposition, tips, and tricks. <em>Journal of Vascular Surgery</em>, <em>49</em>(1), 251–254. <a href="https://doi.org/10.1016/j.jvs.2008.10.035">https://doi.org/10.1016/j.jvs.2008.10.035</a>
</div>
<div id="ref-cuaReviewCoronarySubclavian2017" class="csl-entry">
120. Cua, B., Mamdani, N., Halpin, D., Jhamnani, S., Jayasuriya, S., &amp; Mena-Hurtado, C. (2017). Review of coronary subclavian steal syndrome. <em>Journal of Cardiology</em>, <em>70</em>(5), 432–437. <a href="https://doi.org/10.1016/j.jjcc.2017.02.012">https://doi.org/10.1016/j.jjcc.2017.02.012</a>
</div>
<div id="ref-cheun2019" class="csl-entry">
121. Cheun, T. J., Jayakumar, L., Sheehan, M. K., Sideman, M. J., Pounds, L. L., &amp; Davies, M. G. (2019). Outcomes of upper extremity interventions for chronic critical ischemia. <em>Journal of Vascular Surgery</em>, <em>69</em>(1), 120–128.e2. <a href="https://doi.org/10.1016/j.jvs.2018.04.056">https://doi.org/10.1016/j.jvs.2018.04.056</a>
</div>
<div id="ref-dineen2007" class="csl-entry">
123. Dineen, S., Smith, S., &amp; Arko, F. R. (2007). Successful percutaneous angioplasty and stenting of the radial artery in a patient with chronic upper extremity ischemia and digital gangrene. <em>Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists</em>, <em>14</em>(3), 426–428. <a href="https://doi.org/10.1583/06-2017.1">https://doi.org/10.1583/06-2017.1</a>
</div>
<div id="ref-chang2003" class="csl-entry">
124. Chang, B. B., Roddy, S. P., Darling, R. C., Maharaj, D., Paty, P. S. K., Kreienberg, P. B., Ozsvath, K. J., Mehta, M., &amp; Shah, D. M. (2003). Upper extremity bypass grafting for limb salvage in end-stage renal failure. <em>Journal of Vascular Surgery</em>, <em>38</em>(6), 1313–1315. <a href="https://doi.org/10.1016/s0741-5214(03)00773-0">https://doi.org/10.1016/s0741-5214(03)00773-0</a>
</div>
<div id="ref-spinelli2010" class="csl-entry">
126. Spinelli, F., Benedetto, F., Passari, G., La Spada, M., Carella, G., Stilo, F., De Caridi, G., &amp; Lentini, S. (2010). Bypass surgery for the treatment of upper limb chronic ischaemia. <em>European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery</em>, <em>39</em>(2), 165–170. <a href="https://doi.org/10.1016/j.ejvs.2009.10.015">https://doi.org/10.1016/j.ejvs.2009.10.015</a>
</div>
<div id="ref-landry2018" class="csl-entry">
127. Landry, G. J., Mostul, C. J., Ahn, D. S., McLafferty, B. J., Liem, T. K., Mitchell, E. L., Jung, E., Abraham, C. Z., Azarbal, A. F., McLafferty, R. B., &amp; al., et. (2018). Causes and outcomes of finger ischemia in hospitalized patients in the intensive care unit. <em>Journal of Vascular Surgery</em>, <em>68</em>(5), 1499–1504. <a href="https://doi.org/10.1016/j.jvs.2018.01.050">https://doi.org/10.1016/j.jvs.2018.01.050</a>
</div>
<div id="ref-valentine2005" class="csl-entry">
128. Valentine, R. J., Modrall, J. G., &amp; Clagett, G. P. (2005). Hand ischemia after radial artery cannulation. <em>Journal of the American College of Surgeons</em>, <em>201</em>(1), 18–22. <a href="https://doi.org/10.1016/j.jamcollsurg.2005.01.011">https://doi.org/10.1016/j.jamcollsurg.2005.01.011</a>
</div>
<div id="ref-landry141RaynaudPhenomenon2019" class="csl-entry">
129. Landry, G. J. (2019). 141. <span>Raynaud Phenomenon</span>. In <em>Rutherford <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>. <span>Elsevier Inc.</span>
</div>
<div id="ref-landry2013" class="csl-entry">
130. Landry, G. J. (2013). Current medical and surgical management of raynaud’s syndrome. <em>Journal of Vascular Surgery</em>, <em>57</em>(6), 1710–1716. <a href="https://doi.org/10.1016/j.jvs.2013.03.012">https://doi.org/10.1016/j.jvs.2013.03.012</a>
</div>
<div id="ref-wigley2016" class="csl-entry">
131. Wigley, F. M., &amp; Flavahan, N. A. (2016). Raynaud’s phenomenon. <em>The New England Journal of Medicine</em>, <em>375</em>(6), 556–565. <a href="https://doi.org/10.1056/NEJMra1507638">https://doi.org/10.1056/NEJMra1507638</a>
</div>
<div id="ref-jamescstanleyCurrentTherapyVascular2014" class="csl-entry">
132. Stanley, J. C., Veith, F., &amp; Wakefield, T. W. (2014). <em>Current <span>Therapy</span> in <span>Vascular</span> and <span>Endovascular Surgery</span></em>. <span>Elsevier Health Sciences</span>.
</div>
<div id="ref-lejoncour2018" class="csl-entry">
133. Le Joncour, A., Soudet, S., Dupont, A., Espitia, O., Koskas, F., Cluzel, P., Hatron, P. Y., Emmerich, J., Cacoub, P., Resche‐Rigon, M., &amp; al., et. (2018). Long‐term outcome and prognostic factors of complications in thromboangiitis obliterans (buerger’s disease): A multicenter study of 224 patients. <em>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</em>, <em>7</em>(23), e010677. <a href="https://doi.org/10.1161/JAHA.118.010677">https://doi.org/10.1161/JAHA.118.010677</a>
</div>
<div id="ref-busch2011" class="csl-entry">
134. Busch, K. (2011). Buerger’s disease (thromboangiitis obliterans): Clinical features and assessment by colour duplex ultrasound. <em>Australasian Journal of Ultrasound in Medicine</em>, <em>14</em>(4), 18–22. <a href="https://doi.org/10.1002/j.2205-0140.2011.tb00126.x">https://doi.org/10.1002/j.2205-0140.2011.tb00126.x</a>
</div>
<div id="ref-fujii2011" class="csl-entry">
135. Fujii, Y., Soga, J., Hidaka, T., Hata, T., Idei, N., Fujimura, N., Mikami, S., Maruhashi, T., Kihara, Y., Noma, K., &amp; al., et. (2011). Color doppler flows of corkscrew collaterals in thromboangiitis obliterans (buerger’s disease) using color duplex ultrasonography. <em>Journal of the American College of Cardiology</em>, <em>57</em>(25), 2539. <a href="https://doi.org/10.1016/j.jacc.2010.07.071">https://doi.org/10.1016/j.jacc.2010.07.071</a>
</div>
<div id="ref-olin2018" class="csl-entry">
136. Olin, J. W. (2018). Thromboangiitis obliterans: 110 years old and little progress made. <em>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</em>, <em>7</em>(23), e011214. <a href="https://doi.org/10.1161/JAHA.118.011214">https://doi.org/10.1161/JAHA.118.011214</a>
</div>
<div id="ref-shanmugam137VasculitisOther2019" class="csl-entry">
137. Shanmugam, V. K. (2019). 137. <span>Vasculitis</span> and <span>Other Uncommon Arteriopathies</span>. In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em> (p. 16).
</div>
<div id="ref-weyand2003" class="csl-entry">
138. Weyand, C. M., &amp; Goronzy, J. J. (2003). Medium- and large-vessel vasculitis. <em>The New England Journal of Medicine</em>, <em>349</em>(2), 160–169. <a href="https://doi.org/10.1056/NEJMra022694">https://doi.org/10.1056/NEJMra022694</a>
</div>
<div id="ref-ehlert2019" class="csl-entry">
139. Ehlert, B. A., &amp; Abularrage, C. J. (2019). 139. Takayasu disease. In <em>Rutherford’s vascular surgery and endovascular therapy</em> (9th ed., p. 17). Elsevier Inc.
</div>
<div id="ref-bongartz2006" class="csl-entry">
140. Bongartz, T., &amp; Matteson, E. L. (2006). Large-vessel involvement in giant cell arteritis. <em>Current Opinion in Rheumatology</em>, <em>18</em>(1), 10–17. <a href="https://doi.org/10.1097/01.bor.0000197996.04709.4e">https://doi.org/10.1097/01.bor.0000197996.04709.4e</a>
</div>
<div id="ref-janssen2008" class="csl-entry">
141. Janssen, S. P., Comans, E. H., Voskuyl, A. E., Wisselink, W., &amp; Smulders, Y. M. (2008). Giant cell arteritis: Heterogeneity in clinical presentation and imaging results. <em>Journal of Vascular Surgery</em>, <em>48</em>(4), 1025–1031. <a href="https://doi.org/10.1016/j.jvs.2008.04.054">https://doi.org/10.1016/j.jvs.2008.04.054</a>
</div>
<div id="ref-shanmugam2019" class="csl-entry">
142. Shanmugam, V. K. (2019). 137. Vasculitis and other uncommon arteriopathies. In <em>Rutherford’s vascular surgery and endovascular therapy</em> (p. 16).
</div>
<div id="ref-baig84UpperExtremity2019" class="csl-entry">
143. Baig, m. shadman, &amp; Timaran, C. H. (2019). 84. <span>Upper</span> extremity aneurysms. In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>. <span>Elsevier Inc.</span>
</div>
<div id="ref-mohan2016" class="csl-entry">
144. Mohan, S., Schanzer, A., Robinson, W. P., &amp; Aiello, F. A. (2016). Endovascular management of radiation-induced subclavian and axillary artery aneurysms. <em>Journal of Vascular Surgery</em>, <em>64</em>(4), 1135–1137. <a href="https://doi.org/10.1016/j.jvs.2015.08.073">https://doi.org/10.1016/j.jvs.2015.08.073</a>
</div>
<div id="ref-vierhout2010" class="csl-entry">
145. Vierhout, B. P., Zeebregts, C. J., Dungen, J. J. A. M. van den, &amp; Reijnen, M. M. P. J. (2010). Changing profiles of diagnostic and treatment options in subclavian artery aneurysms. <em>European Journal of Vascular and Endovascular Surgery</em>, <em>40</em>(1), 27–34. <a href="https://doi.org/10.1016/j.ejvs.2010.03.011">https://doi.org/10.1016/j.ejvs.2010.03.011</a>
</div>
<div id="ref-maskanakis2018" class="csl-entry">
146. Maskanakis, A., Patelis, N., Moris, D., Tsilimigras, D. I., Schizas, D., Diakomi, M., Bakoyiannis, C., Georgopoulos, S., Klonaris, C., &amp; Liakakos, T. (2018). Stenting of subclavian artery true and false aneurysms: A systematic review. <em>Annals of Vascular Surgery</em>, <em>47</em>, 291–304. <a href="https://doi.org/10.1016/j.avsg.2017.08.013">https://doi.org/10.1016/j.avsg.2017.08.013</a>
</div>
<div id="ref-treitl2015" class="csl-entry">
147. Treitl, K. M., König, C., Reiser, M. F., &amp; Treitl, M. (2015). Complications of transbrachial arterial access for peripheral endovascular interventions. <em>Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists</em>, <em>22</em>(1), 63–70. <a href="https://doi.org/10.1177/1526602814564363">https://doi.org/10.1177/1526602814564363</a>
</div>
<div id="ref-tosti2017" class="csl-entry">
148. Tosti, R., Özkan, S., Schainfeld, R. M., &amp; Eberlin, K. R. (2017). Radial artery pseudoaneurysm. <em>The Journal of Hand Surgery</em>, <em>42</em>(4), 295.e1–295.e6. <a href="https://doi.org/10.1016/j.jhsa.2017.01.024">https://doi.org/10.1016/j.jhsa.2017.01.024</a>
</div>
<div id="ref-bagir2017" class="csl-entry">
149. Bagir, M., Sayit, E., &amp; Tanrivermis Sayit, A. (2017). Pseudoaneurysm of the radial artery on the hand secondary to stabbing. <em>Annals of Vascular Surgery</em>, <em>41</em>, 280.e7–280.e10. <a href="https://doi.org/10.1016/j.avsg.2016.09.027">https://doi.org/10.1016/j.avsg.2016.09.027</a>
</div>
<div id="ref-eskandari185ConditionsArising2020" class="csl-entry">
150. Eskandari, M. K., &amp; Morgan, C. E. (2020). 185: <span>Conditions Arising From Repetitive Trauma</span> and <span>Occupational Vascular Problems</span>. In <em>Rutherford’s Vascular Surgery and Endovascular Therapy, 2-Volume Set</em>. <span>Elsevier Inc.</span> <a href="https://doi.org/10.1016/B978-0-323-42791-3.00185-7">https://doi.org/10.1016/B978-0-323-42791-3.00185-7</a>
</div>
<div id="ref-ferris2000" class="csl-entry">
151. Ferris, B. L., Taylor, L. M., Oyama, K., McLafferty, R. B., Edwards, J. M., Moneta, G. L., &amp; Porter, J. M. (2000). Hypothenar hammer syndrome: Proposed etiology. <em>Journal of Vascular Surgery</em>, <em>31</em>(1 Pt 1), 104–113. <a href="https://doi.org/10.1016/s0741-5214(00)70072-3">https://doi.org/10.1016/s0741-5214(00)70072-3</a>
</div>
<div id="ref-carr2019" class="csl-entry">
152. Carr, M. P., Becker, G. W., Taljanovic, M. S., &amp; McCurdy, W. E. (2019). Hypothenar hammer syndrome: Case report and literature review. <em>Radiology Case Reports</em>, <em>14</em>(7), 868–871. <a href="https://doi.org/10.1016/j.radcr.2019.04.015">https://doi.org/10.1016/j.radcr.2019.04.015</a>
</div>
<div id="ref-kauvar184VascularTrauma2020" class="csl-entry">
153. Kauvar, D. S., &amp; Kraiss, L. W. (2020). 184: <span>Vascular Trauma</span>: <span>Extremity</span>. In <em>Rutherford’s Vascular Surgery and Endovascular Therapy, 2-Volume Set</em>. <span>Elsevier Inc.</span> <a href="https://doi.org/10.1016/B978-0-323-42791-3.00184-5">https://doi.org/10.1016/B978-0-323-42791-3.00184-5</a>
</div>
<div id="ref-yoon2015" class="csl-entry">
154. Yoon, D. Y., Annambhotla, S., Resnick, S. A., Eskandari, M. K., &amp; Rodriguez, H. E. (2015). Inadvertent arterial placement of central venous catheters: Diagnostic and therapeutic strategies. <em>Annals of Vascular Surgery</em>, <em>29</em>(8), 1567–1574. <a href="https://doi.org/10.1016/j.avsg.2015.05.030">https://doi.org/10.1016/j.avsg.2015.05.030</a>
</div>
<div id="ref-cohen2014" class="csl-entry">
156. Cohen, J. E., Moshe Gomori, J., Anner, H., &amp; Itshayek, E. (2014). Inadvertent subclavian artery cannulation treated by percutaneous closure. <em>Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia</em>, <em>21</em>(11), 1973–1975. <a href="https://doi.org/10.1016/j.jocn.2014.04.009">https://doi.org/10.1016/j.jocn.2014.04.009</a>
</div>
<div id="ref-humphries124ThoracicOutlet2019" class="csl-entry">
157. Humphries, M. D., &amp; Freischlag, J. A. (2019). 124: <span>Thoracic Outlet Syndrome</span> : <span>Surgical Decompression</span> of the <span>Thoracic Outlet</span>. In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em> (Ninth, Vol. 2). <span>Elsevier Inc.</span> <a href="https://doi.org/10.1016/B978-0-323-42791-3.00124-9">https://doi.org/10.1016/B978-0-323-42791-3.00124-9</a>
</div>
<div id="ref-mcminnLastAnatomyRegional2019" class="csl-entry">
158. McMinn, R. H. (2019). <em>Last’s <span>Anatomy</span>: Regional and applied</em>. <span>Elsevier Inc.</span>
</div>
<div id="ref-siracuseInfraclavicularFirstRib2015" class="csl-entry">
159. Siracuse, J. J., Johnston, P. C., Jones, D. W., Gill, H. L., Connolly, P. H., Meltzer, A. J., &amp; Schneider, D. B. (2015). Infraclavicular first rib resection for the treatment of acute venous thoracic outlet syndrome. <em>Journal of Vascular Surgery: Venous and Lymphatic Disorders</em>, <em>3</em>(4), 397–400. <a href="https://doi.org/10.1016/j.jvsv.2015.06.002">https://doi.org/10.1016/j.jvsv.2015.06.002</a>
</div>
<div id="ref-rinehardtCurrentPracticeThoracic2017" class="csl-entry">
160. Rinehardt, E. K., Scarborough, J. E., &amp; Bennett, K. M. (2017). Current practice of thoracic outlet decompression surgery in the <span>United States</span>. <em>Journal of Vascular Surgery</em>, <em>66</em>(3), 858–865. <a href="https://doi.org/10.1016/j.jvs.2017.03.436">https://doi.org/10.1016/j.jvs.2017.03.436</a>
</div>
<div id="ref-delaney2017" class="csl-entry">
161. Delaney, S. W., Shi, H., Shokrani, A., &amp; Sinha, U. K. (2017). Management of chyle leak after head and neck surgery: Review of current treatment strategies. <em>International Journal of Otolaryngology</em>, <em>2017</em>, 8362874. <a href="https://doi.org/10.1155/2017/8362874">https://doi.org/10.1155/2017/8362874</a>
</div>
<div id="ref-cope1999" class="csl-entry">
162. Cope, C., Salem, R., &amp; Kaiser, L. R. (1999). Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: Prospective trial. <em>Journal of Vascular and Interventional Radiology: JVIR</em>, <em>10</em>(9), 1248–1254. <a href="https://doi.org/10.1016/s1051-0443(99)70227-7">https://doi.org/10.1016/s1051-0443(99)70227-7</a>
</div>
<div id="ref-illigComprehensiveReviewPagetSchroetter2010" class="csl-entry">
163. Illig, K. A., &amp; Doyle, A. J. (2010). A comprehensive review of <span>Paget-Schroetter</span> syndrome. <em>Journal of Vascular Surgery</em>, <em>51</em>(6), 1538–1547. <a href="https://doi.org/10.1016/j.jvs.2009.12.022">https://doi.org/10.1016/j.jvs.2009.12.022</a>
</div>
<div id="ref-humphries123ThoracicOutlet2019" class="csl-entry">
164. Humphries, M. D., &amp; Freischlag, J. A. (2019). 123: <span>Thoracic</span> outlet syndrome: <span>Venous</span>. In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em> (Vol. 2, pp. 1648–1655.e2). <span>Elsevier Inc.</span> <a href="https://doi.org/10.1016/j.mpsur.2018.12.010">https://doi.org/10.1016/j.mpsur.2018.12.010</a>
</div>
<div id="ref-sekharYearbookVascularEndovascular2018" class="csl-entry">
165. Sekhar, R. (2018). <em>Yearbook of vascular and endovascular surgery-2, 2018</em>. <span>JAYPEE Brothers MEDICAL P</span>.
</div>
<div id="ref-kearonAntithromboticTherapyVTE2016" class="csl-entry">
166. Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., Stevens, S. M., Vintch, J. R. E., Wells, P., Woller, S. C., &amp; Moores, L. (2016). Antithrombotic <span>Therapy</span> for <span>VTE Disease</span>. <em>Chest</em>, <em>149</em>(2), 315–352. <a href="https://doi.org/10.1016/j.chest.2015.11.026">https://doi.org/10.1016/j.chest.2015.11.026</a>
</div>
<div id="ref-urschelSurgeryRemainsMost2008" class="csl-entry">
167. Urschel, H. C., &amp; Patel, A. N. (2008). Surgery <span>Remains</span> the <span>Most Effective Treatment</span> for <span>Paget-Schroetter Syndrome</span>: 50 <span>Years</span>’ <span>Experience</span>. <em>The Annals of Thoracic Surgery</em>, <em>86</em>(1), 254–260. <a href="https://doi.org/10.1016/j.athoracsur.2008.03.021">https://doi.org/10.1016/j.athoracsur.2008.03.021</a>
</div>
<div id="ref-grunwaldCatheterDirectedThrombolysisTreatment2004" class="csl-entry">
168. Grunwald, M. R., &amp; Hofmann, L. V. (2004). Catheter-<span>Directed Thrombolysis</span> for the <span>Treatment</span> of <span>Symptomatic Deep Vein Thrombosis</span>. <em>Circulation</em>, <em>109</em>(2). <a href="https://doi.org/10.1161/01.CIR.0000111132.23469.70">https://doi.org/10.1161/01.CIR.0000111132.23469.70</a>
</div>
<div id="ref-wilsonFibrinolyticTherapyIdiopathic1990" class="csl-entry">
169. Wilson, J. J., Zahn, C. A., &amp; Newman, H. (1990). Fibrinolytic therapy for idiopathic subclavian-axillary vein thrombosis. <em>The American Journal of Surgery</em>, <em>159</em>(2), 208–210. <a href="https://doi.org/10.1016/S0002-9610(05)80262-4">https://doi.org/10.1016/S0002-9610(05)80262-4</a>
</div>
<div id="ref-melbyComprehensiveSurgicalManagement2008" class="csl-entry">
170. Melby, S. J., Vedantham, S., Narra, V. R., Paletta, G. A., Khoo-Summers, L., Driskill, M., &amp; Thompson, R. W. (2008). Comprehensive surgical management of the competitive athlete with effort thrombosis of the subclavian vein (<span>Paget-Schroetter</span> syndrome). <em>Journal of Vascular Surgery</em>, <em>47</em>(4), 809–820.e3. <a href="https://doi.org/10.1016/j.jvs.2007.10.057">https://doi.org/10.1016/j.jvs.2007.10.057</a>
</div>
<div id="ref-vemuriDiagnosisTreatmentEffortinduced2016" class="csl-entry">
171. Vemuri, C., Salehi, P., Benarroch-Gampel, J., McLaughlin, L. N., &amp; Thompson, R. W. (2016). Diagnosis and treatment of effort-induced thrombosis of the axillary subclavian vein due to venous thoracic outlet syndrome. <em>Journal of Vascular Surgery: Venous and Lymphatic Disorders</em>, <em>4</em>(4), 485–500. <a href="https://doi.org/10.1016/j.jvsv.2016.01.004">https://doi.org/10.1016/j.jvsv.2016.01.004</a>
</div>
<div id="ref-molinaPagetSchroetterSyndromeTreated2007" class="csl-entry">
172. Molina, J. E., Hunter, D. W., &amp; Dietz, C. A. (2007). Paget-<span>Schroetter</span> syndrome treated with thrombolytics and immediate surgery. <em>Journal of Vascular Surgery</em>, <em>45</em>(2), 328–334. <a href="https://doi.org/10.1016/j.jvs.2006.09.052">https://doi.org/10.1016/j.jvs.2006.09.052</a>
</div>
<div id="ref-changRoutineVenographyFollowing2012" class="csl-entry">
173. Chang, K. Z., Likes, K., Demos, J., Black, J. H., &amp; Freischlag, J. A. (2012). Routine <span>Venography Following Transaxillary First Rib Resection</span> and <span>Scalenectomy</span> (<span>FRRS</span>) for <span>Chronic Subclavian Vein Thrombosis Ensures Excellent Outcomes</span> and <span>Vein Patency</span>. <em>Vascular and Endovascular Surgery</em>, <em>46</em>(1), 15–20. <a href="https://doi.org/10.1177/1538574411423982">https://doi.org/10.1177/1538574411423982</a>
</div>
<div id="ref-lugoAcutePagetSchroetter2015" class="csl-entry">
174. Lugo, J., Tanious, A., Armstrong, P., Back, M., Johnson, B., Shames, M., Moudgill, N., Nelson, P., &amp; Illig, K. A. (2015). Acute <span>Paget</span>: <span>Does</span> the <span>First Rib Routinely Need</span> to <span>Be Removed</span> after <span>Thrombolysis</span>? <em>Annals of Vascular Surgery</em>, <em>29</em>(6), 1073–1077. <a href="https://doi.org/10.1016/j.avsg.2015.02.006">https://doi.org/10.1016/j.avsg.2015.02.006</a>
</div>
<div id="ref-sajidUpperLimbDeep2007" class="csl-entry">
175. Sajid, M. S., Ahmed, N., Desai, M., Baker, D., &amp; Hamilton, G. (2007). Upper <span>Limb Deep Vein Thrombosis</span>: <span>A Literature Review</span> to <span>Streamline</span> the <span>Protocol</span> for <span>Management</span>. <em>Acta Haematologica</em>, <em>118</em>(1), 10–18. <a href="https://doi.org/10.1159/000101700">https://doi.org/10.1159/000101700</a>
</div>
<div id="ref-boll122ThoracicOutlet2019" class="csl-entry">
176. Boll, J. M., &amp; Valentine, R. J. (2019). 122: <span>Thoracic</span> outlet syndrome: <span>Arterial</span>. In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em> (Ninth, Vol. 2). <span>Elsevier Health Sciences</span>.
</div>
<div id="ref-vemuriClinicalPresentationManagement2017" class="csl-entry">
177. Vemuri, C., McLaughlin, L. N., Abuirqeba, A. A., &amp; Thompson, R. W. (2017). Clinical presentation and management of arterial thoracic outlet syndrome. <em>Journal of Vascular Surgery</em>, <em>65</em>(5), 1429–1439. <a href="https://doi.org/10.1016/j.jvs.2016.11.039">https://doi.org/10.1016/j.jvs.2016.11.039</a>
</div>
<div id="ref-criadoSpectrumArterialCompression2010" class="csl-entry">
178. Criado, E., Berguer, R., &amp; Greenfield, L. (2010). The spectrum of arterial compression at the thoracic outlet. <em>Journal of Vascular Surgery</em>, <em>52</em>(2), 406–411. <a href="https://doi.org/10.1016/j.jvs.2010.03.009">https://doi.org/10.1016/j.jvs.2010.03.009</a>
</div>
<div id="ref-sadeghi-azandaryaniThoracicOutletSyndrome2009" class="csl-entry">
179. Sadeghi-Azandaryani, M., Bürklein, D., Ozimek, A., Geiger, C., Mendl, N., Steckmeier, B., &amp; Heyn, J. (2009). Thoracic outlet syndrome: Do we have clinical tests as predictors for the outcome after surgery? <em>European Journal of Medical Research</em>, <em>14</em>(10), 443–446. <a href="https://doi.org/10.1186/2047-783X-14-10-443">https://doi.org/10.1186/2047-783X-14-10-443</a>
</div>
<div id="ref-sandersDiagnosisThoracicOutlet2007" class="csl-entry">
180. Sanders, R. J., Hammond, S. L., &amp; Rao, N. M. (2007). Diagnosis of thoracic outlet syndrome. <em>Journal of Vascular Surgery</em>, <em>46</em>(3), 601–604. <a href="https://doi.org/10.1016/j.jvs.2007.04.050">https://doi.org/10.1016/j.jvs.2007.04.050</a>
</div>
<div id="ref-baldermanPhysicalTherapyManagement2019" class="csl-entry">
181. Balderman, J., Abuirqeba, A. A., Eichaker, L., Pate, C., Earley, J. A., Bottros, M. M., Jayarajan, S. N., &amp; Thompson, R. W. (2019). Physical therapy management, surgical treatment, and patient-reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndrome. <em>Journal of Vascular Surgery</em>, <em>70</em>(3), 832–841. <a href="https://doi.org/10.1016/j.jvs.2018.12.027">https://doi.org/10.1016/j.jvs.2018.12.027</a>
</div>
<div id="ref-salhanPC214UltrasoundGuidedAnesthetic2016" class="csl-entry">
182. Salhan, N., Humphries, M., Sheth, S., DeMesa, C., &amp; Freischlag, J. (2016). <span>PC214</span>. <span>Ultrasound-Guided Anesthetic</span> or <span>Botulinum Toxin Injection</span> of the <span>Anterior</span> and <span>Middle Scalene Muscles</span> to <span>Assist With Diagnosis</span> and <span>Treatment</span> of <span>Neurogenic Thoracic Outlet Syndrome</span>. <em>Journal of Vascular Surgery</em>, <em>63</em>(6), 218S. <a href="https://doi.org/10.1016/j.jvs.2016.03.365">https://doi.org/10.1016/j.jvs.2016.03.365</a>
</div>
<div id="ref-lumImpactAnteriorScalene2012" class="csl-entry">
183. Lum, Y. W., Brooke, B. S., Likes, K., Modi, M., Grunebach, H., Christo, P. J., &amp; Freischlag, J. A. (2012). Impact of anterior scalene lidocaine blocks on predicting surgical success in older patients with neurogenic thoracic outlet syndrome. <em>Journal of Vascular Surgery</em>, <em>55</em>(5), 1370–1375. <a href="https://doi.org/10.1016/j.jvs.2011.11.132">https://doi.org/10.1016/j.jvs.2011.11.132</a>
</div>
<div id="ref-morrell2005" class="csl-entry">
184. Morrell, R. M., Halyard, M. Y., Schild, S. E., Ali, M. S., Gunderson, L. L., &amp; Pockaj, B. A. (2005). Breast cancer-related lymphedema. <em>Mayo Clinic Proceedings</em>, <em>80</em>(11), 1480–1484. <a href="https://doi.org/10.4065/80.11.1480">https://doi.org/10.4065/80.11.1480</a>
</div>
<div id="ref-mondry2004" class="csl-entry">
185. Mondry, T. E., Riffenburgh, R. H., &amp; Johnstone, P. A. S. (2004). Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. <em>Cancer Journal (Sudbury, Mass.)</em>, <em>10</em>(1), 42-48; discussion 17-19. <a href="https://doi.org/10.1097/00130404-200401000-00009">https://doi.org/10.1097/00130404-200401000-00009</a>
</div>
<div id="ref-warren2007" class="csl-entry">
186. Warren, A. G., Brorson, H., Borud, L. J., &amp; Slavin, S. A. (2007). Lymphedema: A comprehensive review. <em>Annals of Plastic Surgery</em>, <em>59</em>(4), 464–472. <a href="https://doi.org/10.1097/01.sap.0000257149.42922.7e">https://doi.org/10.1097/01.sap.0000257149.42922.7e</a>
</div>
<div id="ref-sharma2012" class="csl-entry">
187. Sharma, A., &amp; Schwartz, R. A. (2012). Stewart-treves syndrome: Pathogenesis and management. <em>Journal of the American Academy of Dermatology</em>, <em>67</em>(6), 1342–1348. <a href="https://doi.org/10.1016/j.jaad.2012.04.028">https://doi.org/10.1016/j.jaad.2012.04.028</a>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="cerebrovascular.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="abdominal-aneurysms.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": false,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": false,
"email": true
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/adam-mdmph/VS-Exam-Prep/blob/main/02-upper-extremity.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["_main.pdf"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true
},
"info": false
});
});
</script>

</body>

</html>
